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In this chapter, I will highlight the importance of the microenvironmental cues in 
regulating the metastatic potential of cancer cells. I will focus on the mechanical cues of 
the cancer microenvironment and how it affects the final fate of the metastatic disease. 
This will lead us to recognize the importance of the topographic cues of the cellular niche 
and identify the unanswered questions in the field of topographic regulation of cancer cell 
proliferation. Finally, I will discuss the underlying hypothesis and objectives towards 
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1.1. What are the roles of microenvironmental cues during cancer metastasis? 
During the process of metastasis, cancer cells can spread from the primary tumor 
to specific distant secondary locations through the blood or lymphatic circulatory system. 
The secondary location for metastasis is restricted to specific target organs for particular 
types of cancer. For instance, breast cancer preferentially metastasizes to bone, brain, 
liver and lung [1].  However, for other cancers such as prostate cancer, metastasis 
happens only to bone [2]. The reason for this specific choice of secondary niche can be 
explained by the ‘seed and soil hypothesis’ by Stephen Paget and the ‘mechanical 
hypothesis’ by James Ewing. According to the ‘seed and soil hypothesis’, the cancer cells 
(‘seed’) selectively grow and proliferate in a microenvironment (‘soil’) that is conducive 
for its growth [3].  Recently, it was observed that exosomes could direct pre-metastatic 
microenvironment formation by fusing with the target cells and blocking the specific 
integrin receptors prevented organ-specific metastasis [4]. The ‘mechanical hypothesis’ 
suggests that the circulatory pattern of blood flow dictates the specific secondary niche 
[5]. Both these hypothesizes are not mutually exclusive and current studies suggest a role 
for both of them [6]. Another interesting feature of metastasis is the spatio-temporal 
kinetics of the disease; such as breast and lung cancer colonize to similar secondary 
organs. However, breast cancer relapses after years or decades from first diagnosis [7] 
and for lung cancer, distant macro-metastases are established within a few months [8]. 
Due to the hostile microenvironment in the secondary location, the disseminated tumor 
cells (DTCs) might lose their proliferation ability and enter dormancy for an indefinite 
time or they proliferate slowly into micro-metastases as the proliferation rate balances 
with that of cell death. Therefore, the complex yet dynamic microenvironment that the 
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cancer cells encounter during the course of their metastatic journey plays a critical role in 
deciding the final fate of the disease. 
 
 
1.2. Importance of mechanical cues in regulating metastasis 
Over the last decade, it has been observed that the mechanical cues of the tumor 
microenvironment including matrix stiffness [9], topography [10], confinement [11], 
shear stress [12] and mechanical stretching [13] can dictate the behavior of cancer cells 
(Fig 1.1.). For instance, highly metastatic melanoma cells (B16-F1) can be selected by 
culturing them in a soft fibrin matrix [14]. The higher stiffness of the breast tumor 
microenvironment promotes malignant phenotype of the mammary epithelium by 
controlling the integrin expression and signaling [15, 16]. The extracellular matrix 
(ECM) can either favor cancer progression [16] or induce invasive cells to behave in a 
healthy manner [17]. Therefore, fine-tuning of the mechanical micro-environmental cues 
is essential in influencing cancer growth and development.  




Figure 1.1. Mechanical landscape of metastasis. Schematic diagram showing the effect 
of various mechanical cues during the progress of the metastatic disease. In the primary 
tumor, the cells are exposed to compressive stress from the surrounding 
microenvironment and mechanical stretching due to the hyper proliferation of the cancer 
cells. Additionally, the ECM stiffens and arranges themselves in an anisotropic 
orientation due to the activity of the stromal cells such as cancer-associated fibroblasts 
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(CAFs), macrophages to facilitate the invasion of the cancer cells towards the blood 
circulatory system. Within the circulation, the single circulating tumor cells (CTCs) and 
tumor microemboli are exposed to shear stress and they are arrested in the narrow blood 
capillaries, where they undergo extravasation and subsequently form micro-metastases at 
specific secondary niches such as bone, brain, liver, lung. 
 
1.3. Motivation of the thesis 
Metastasis is the leading cause of cancer related mortality. Various soluble factors 
secreted by the stromal cells of the tumor microenvironment contribute to the 
proliferation and colonization efficiency of the cancer cells in the metastatic location. 
Alongside the biochemical cues, cancer cells are also simultaneously exposed to a wide 
range of physical cues including ECM stiffness, dimensionality, and topography. 
Although the role of stiffness on proliferative response of cancer cells has been well 
studied, little is known about the effect of topographic cues in guiding cancer cell 
proliferation. Abercrombie et al. observed that tumor cells might be contact guided by 
the underlying normal cells and this leads to greater metastatic potential [18]. In another 
study, Nikkhah M et al. used silicon microwell structures of 150µm diameter and 68µm 
depth to study the adhesion efficiency of cancer cell with respect to fibroblasts. They 
observed that unlike fibroblasts, breast cancer cells tend to form stable adhesion along the 
curve surfaces due to their easily deformable cytoskeleton [19]. Cancer cell proliferation 
is also guided by the substrate stiffness of the matrix. By varying the substrate stiffness 
from 0.8-120kPa, Ulrich T. A. et al. showed a positive correlation between the number of 
proliferating cells and substrate stiffness [20].  
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However, it is not well understood: 
 
 
1. What is the role of topographic cues in the physical microenvironment in guiding 
cancer cell proliferation? 
2. What are the signaling pathways involved in sensing these physical cues and 
thereby regulating proliferation efficiency? 
3. Can the combination of mechanical cues and drugs targeting the signaling 
pathways be used to inhibit cancer cell proliferation? 
 
1.4. Hypothesis and objectives 
In this thesis, we hypothesized that topographic cue provided by the cancer 
microenvironment induces differential sensitivity on cancer cell proliferation via 
regulation of actomyosin contractility. The architecture of the ECM of the metastatic 
niche comprises topographic features in the sub-micron range. It is interesting to 
understand how such topographic cues affect the proliferation efficiency of the cancer 
cells and what are the signaling pathways involved in the transduction of the mechanical 
cues. To address these questions, two main sets of experiments were performed using 
breast cancer cell lines as the model cell types.  
Firstly, we sought to understand the role of topographic cues of the primary breast 
tumor microenvironment in influencing proliferation. Following are the objectives for 
the first part of thesis: 
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1. To mimic the topographic cues of primary breast tumor microenvironment in-
vitro and study the proliferation of different breast cell lines such as non-cancer 
breast epithelial cells (MCF-10A), non-metastatic breast cancer cells (MCF-7) 
and metastatic breast cancer cells (MDA-MB-231). 
2. To understand the dynamics of the topography induced proliferation change and 
the physical mechanisms involved in sensing such cues. 
3. To elucidate the mechanotransduction signaling pathways involved in the 
transduction of the mechanical cues into biochemical responses and proliferation 
changes.  
Beside the primary breast tumor microenvironment, we also focused on the role of 
the topographic cues from the secondary breast tumor microenvironment. Breast 
cancer metastasizes specifically to bone, brain, liver and lung. Among them, bone is one 
of the principal secondary locations and is composed of a fluid-filled porous matrix. 
Following were the objectives for the second part of the thesis: 
1. To replicate the porous microenvironment of the bone in-vitro using 
microfabrication techniques. The depth and width of the pores were varied 
between 1-10 µm and the proliferation ability of the model breast cancer cell lines 
quantified. 
2. To characterize the dynamics of the mechanotransduction process and identify the 
cellular structures involved in sensing the depth of the matrix. 
3. To understand the differential regulation of the actomyosin contractility in healthy 
and cancer cell lines in response to the porous microenvironment.  
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This study will provide deeper insights in understanding the biochemical and 
physical mechanisms involved in the topography-induced proliferation changes of 
breast cancer cells. The microfabrication and microscopic techniques used in the 
thesis will help to better mimic the topographic cues under in-vitro conditions and 
control the proliferation of the cancer cells. The underlying knowledge of the 
mechanotransduction process will provide a foundation for designing potential drug 
targets by unraveling the intricate mechanisms in the cancer microenvironment. 
However, this thesis did not investigate the different biochemical environmental cues 
















In this review chapter, I will first highlight the mechanical cues of the tumor 
microenvironment that regulate the growth and proliferation of cancer cells (Fig 2.1., 
Table 2.1.). I will then decipher how these mechanical cues are transduced into specific 
biochemical responses (Fig 2.2.) and describe recent technological advancements used in 
quantifying these parameters (Fig 2.3.). I will conclude by summarizing the potential 
applications of the field of mechanomedicine in treating cancer by targeting anti-cancer 
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2.1. Mechanical cues regulating cancer growth 
2.1.1. Matrix stiffness 
 
During breast cancer progression, the mammary matrix density and stiffness 
increases compared to a healthy person due to greater collagen crosslinking by lysyl 
oxidase. The higher stiffness of the breast epithelium is correlated with 4 to 6 times 
higher risk of developing breast tumor [21]. In healthy and H-ras-transformed fibroblasts, 
it was observed that soft matrix inhibited the growth of healthy cells and induced 
apoptosis. However, transformed cells were not responsive to these growth inhibitory 
mechanical cues and continued their uncontrolled proliferation [22]. In another study, the 
concept of ‘tissue tropism’ was observed with respect to rigidity sensing mechanism of 
cancer cells. Tumor cells preferentially showed greater proliferation and malignant 
behavior when the matrix rigidity corresponded to that of the target organs where 
metastasis would occur [23]. Breast cancer cells (MDA-MB-231) metastasizing to bone 
prefer stiff matrix whereas ovarian cancer cells (SKOV-3) that metastasize to soft 
omentum fat pad prefer more compliant substrate. Recently, it was understood that the 
actomyosin contractility plays a crucial role in determining tissue tropism [9, 24]. On soft 
substrates, ovarian cancer cells exerted higher traction forces and underwent epithelial-to-
mesenchymal transition (EMT) [24]. In the case of glioblastoma multiforme (GBM) 
tumors that are stiffer than healthy parenchyma, cells showed increased proliferation with 
formation of prominent stress fibers and focal adhesions on rigid matrix [25]. Based on 
the proliferative response of different cancer cells lines on substrates of varying rigidity, 
it was believed that rigidity sensing is an intrinsic property of the individual cell line. 
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Cells are classified as ‘rigidity dependent’ when cell growth is regulated by the matrix 
stiffness (e.g. MDA-MB-231) and ‘rigidity independent’, where cells proliferate at the 
same rate regardless of the rigidity of the matrix (e.g. PC-3) [26]. Therefore, the 
proliferation of cancer cells on rigidity of different matrices is dependent on the particular 
types of cancer and cellular contractility plays a key role in determining this response.  
 
2.1.2. Topography  
 
The organization and topography of the collagen ECM fibers undergo dynamic 
changes (tumor-associated collagen signature (TACS)) during the progression of the 
metastatic disease [27].  In a healthy individual, the collagen fibers are arranged in a 
random isotropic arrangement (TACS-1); however, during tumor advancement the fibers 
arrange themselves in a parallel anisotropic orientation (TACS-3) [28]. TACS-3 
topography of the ECM fibers facilitates the migration of the breast cancer cells away 
from the primary tumor with greater persistence and velocity [29]. In another study, 
topographic features comprising gratings and square pits with dimensions of 15 to 500 
µm did not affect the proliferation of MDA-MB-231 and MCF-7, and this may be 
because the cancer cells were unable to sense such large structures (the size of the cell is 
around 20 µm) [30].  When lung cancer cells were cultured on nano-featured surfaces, it 
was observed that proliferation increased on 300 nm surface but reduced on 400 nm 
surface and 23 nm surface induced apoptosis [31]. Micropillar topographies were used to 
study the effect of nuclear deformation on cell proliferation and it was observed that the 
proliferation of healthy cells but not cervical cancer cells (HeLa) decreased on such 
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micro features. Healthy cells have a greater nuclear lamina and higher expression of 
lamin A/C compared to that of cancer cells, which might provide nuclear mechanical 
resistance against deformation [32].  
 
2.1.3. Compressive stress 
 
Due to uncontrolled proliferation and growth of cancer cells, tumor exerts 
pressure on the ECM and neighboring tissues, which in turn exerts compressive forces or 
stresses on the tumor. When human colon carcinoma spheroids were cultured in agarose 
gel, it was observed that the spheroids can grow to a maximum diameter of 400 mm in 
0.5% (w/v) agarose but when compression was increased for 1% (w/v) agarose, only 50 
mm spheroids was formed [33]. Such growth inhibition of tumor spheroids along with 
increasing concentration of agarose gel might be attributed to increased cell packing, 
reduced proliferation and triggering of compression induced apoptosis via the 
mitochondrial pathway in the regions of high solid stress [34]. Tumor growth associated 
mechanical compressive stress induces a mitotic arrest in a population of the spheroid by 
impairing bipolar spindle formation during mitosis [35]. Although compressive stresses 
have a beneficial effect of reducing tumor growth, it might also have a harmful 
consequence by triggering peripheral cancer cell invasion and metastasis [36, 37]. 
Metastasizing cancer cells might get trapped within the narrow capillaries of the 
circulatory system and acquire an elongated cylindrical shape. Such tubular confinement 
of the cells affects the morphology and kinetics of the spindle formation, thereby 
resulting in impaired cell division [11].  




2.1.4. Shear stress  
 
Cancer cells are exposed to two types of shear stress in-vivo such as, stress 
generated by the interstitial flow within the tumor niche and stress produced by the blood 
flow within the circulatory system. Fluid shear stress generated by blood flow ranges 
from 0.5 - 4.0 dynes/cm2 in the venous circulation and 4.0 – 30.0 dynes/cm2 in the arterial 
circulation [38]. When colon cancer cells were exposed to laminar shear stress of 1.2 
dyne/cm2, proliferation of the cells was not affected under shear stress and static 
condition [39]. However, shear stress of 15 dynes/cm2 for 24 hours induced G1 arrest of 
colon cancer cell cycle progression via the activation of α6β4 integrin [40]. Interestingly, 
in human osteosarcoma cells, 12 dynes/cm2 of shear stress induced G2/M cell cycle 
blockage by the activation of αvβ3 and β1 integrins [12]. Therefore, shear stress triggers 
cancer cell cycle arrest via the activation of integrin receptors and this 
mechanotransduction process is dependent on particular cancer types and magnitude of 
shear stress applied. 
 
2.1.5. Mechanical stretching  
 
Tumor interstitial fluid pressure (TIFP) is higher in most solid tumors and is due 
to the abnormalities in the lymphatic circulation and tumor vasculature [41]. TIFP 
generates hypertension and mechanical stretching that increases the proliferation of 
cancer cells [42]. Uniaxial stretching of 1 Hz increases the proliferation of osteosarcoma 
cells via higher expression of phospholipase C (PLC) b2 [43]. Static stretching for 6 
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hours triggers activation of YAP/TAZ and re-entry of contact-inhibited epithelial cells 
into the S-phase of cell cycle [13] . Thus, mechanical stretching could overcome the 
growth arrest induced by contact inhibition via the activation and nuclear translocation of 




Figure 2.1. Mechanical cues affecting cancer growth. Stiffness: On soft substrates, 
cells spread less and have short actin filaments, however, on stiff substrates cells 
undertake a polarized morphology and develop stress fibers. Tumor cells preferentially 
shows higher proliferation on matrix rigidity corresponding to their secondary locations. 
For instance, breast cancer prefers stiff matrix whereas ovarian cancer prefers soft matrix. 
Reproduced with permission from [44]. Topography: During the progression of breast 
cancer metastasis, the ECM fibers arrange themselves in a parallel anisotropic orientation 
(TACS) and this helps in the invasion of the cancer cells away from the primary tumor 
with greater velocity and persistence. Stretching: Due to the abnormalities in the tumor 
vasculature, TIFP is greater in most solid tumors and it generates hypertension and 
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mechanical stretching to increase cancer cell proliferation. Confinement: CTCs might get 
trapped within the narrow capillaries of the circulatory system and acquire an elongated 
morphology, which results in impaired cell division. Shear stress: Within the circulatory 
system, cancer cells are exposed to shear stress and it triggers cell cycle arrest via the 
activation of integrin receptors. WBC: white blood cells, RBC:  red blood cells. 
 
Table 2.1. List of mechanical cues affecting cancer growth 
Mechanical 
cues 
Experimental design Effect on growth Cell types Refer
ences 
Matrix stiffness Polyacrylamide substrates. 
Young’s modulus between 
4.7 and 14 kN/m2. 
Soft substrate decreased normal cell 
proliferation and induced apoptosis. 





 Polyacrylamide gels. Young’s 
modulus between 0.6 and 3 
kPa. 
‘Tissue tropism’ 
Increased growth when the matrix 
stiffness is similar to that of the target 
organs where metastasis will occur 
Single cell populations 
isolated from metastatic 
breast cancer cell line 
(MDA-MB-231)  
[23] 
 Polyacrylamide gels. Young’s 
modulus between 0.08 and 
119 kPa. 
Cell proliferation increased on rigid 
substrates and vice versa 
Glioma cell lines [25] 
 Polyacrylamide gels. 
Young’s modulus between 
0.15 – 19.2 kPa. 
Rigidity dependent (Cell growth 
depends on matrix stiffness,). Rigidity 
independent (Cell growth do not 
depends on matrix stiffness) 




 Polyacrylamide substrates. 
Young’s modulus between 
2.83 - 34.88 kPa 
MDA-MB-231 prefers rigid substrate 
and SKOV-3 prefers soft substrate. 
MDA-MB-231, SKOV-3 [9, 24] 
Topography Polystyrene (PS) and poly-L-
lactide (PLLA) substrates. 
Gratings and square pits 
topographic features of 15 to 
500 µm dimension. 
MDA-MB-231 and MCF-7 
proliferation not affected. 
MDA-MB-231, MCF-7 [30] 
 Poly-lactic-co-glycolic 
(PLGA) films. Hemispherical 
beads of width 23, 300, 400 
nm 
Proliferation reduced on 400 nm, 
Increased on 300 nm. Apoptosis 
increased on 23 nm. 
A549 [31] 
 PDMS substrates. Micropillar 
diameter, length, and center-
to-center distance of 3, 9, and 
9 µm respectively. 
Proliferation of SMCs but not HeLa 
decreased on the micropillars. 
HeLa cells, smooth 





0.3 - 1% (w/v) agarose gel. 
 
Spheroids attain maximum diameter 
of 400 mm in 0.5% (w/v) agarose but 
50 mm diameter for 1% (w/v) 
agarose. 






 Co-embedded single cancer 
cells with fluorescent micro-
beads in 2.0% (w/v) agarose 
gels. 







 PDMS devices were designed 
to restrict tumor spheroids 
growth. 
Mechanical stress impairs mitotic 
progression. 




 Tumor spheroids are cultured 
in permeable elastic capsules. 
Stress slows down tumor evolution 
but triggers cell invasion. 
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 Pressing cells against a 
membrane surface with a 
weighted piston. 
Stress enhances the migration 
potential independent of any changes 
in cell proliferation. 
Mammary cancer 
(MCF7, 67NR, 4T1, and 
MDA-MB-231) 
and normal (MCF10A) 
cells 
[37] 
 Tubular confinement of cells 
inside 3D rolled-up, 
transparent nanomembranes. 
Confinement affects spindle 
formation and impairs cell division 
HeLa cells [11] 
Shear stress Laminar shear stress of 1.2 
dyne/cm2 
Proliferation of the cells was not 
affected. 
Colon cancer cells (RKO 
and HCT-8) 
[39] 
 Shear stress of 15 dynes/cm2 G1 arrest of cell cycle progression. Colon cancer cells 
(SW480 and HT29) 
[40] 





Tumor interstitial fluid 
pressure of 5 and 10 mm Hg. 
 
Stretching increases proliferation Epithelial tumors (A431, 
A549) were transplanted 
into nude mice. 
[42] 
 Uniaxial stretching of 1 Hz Stretching increases proliferation Osteosarcoma cell lines 
MG-63, HOS/MNNG, 
OST, U-2/OS, SaOS-2 
[43] 
 Static stretching for 6 hours Stretching triggers re-entry of 
contact-inhibited cells into the S-
phase of cell cycle. 




2.2. Mechanisms of cancer mechanotransduction 
2.2.1. Cell surface receptors and ion channels 	
The progression of a tumor to a highly invasive, metastatic phenotype requires the 
interaction of the cells with various parameters of the ECM such as composition, stiffness 
and architecture. Mounting evidences suggests that such physical cues can be sensed by 
the integrin receptors and transduced into biochemical signaling events, which 
subsequently leads to cancer metastasis [45]. Integrins are heterodimeric transmembrane 
receptors composed of α and β subunits and there are 24 different types of integrin 
receptors in mammals that recognize different ECM ligands [46]. The effect of ECM 
stiffness on cancer cell phenotype is dependent on the composition of the matrix and the 
type of integrin receptors involved to sense it [47]. Previous in-vivo and in-vitro studies 
have observed that the β1-subunits play a key role in the switching of dormant cancer 
cells to malignant growth [48, 49]. Therefore, it provides a potential target for therapeutic 
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intervention. In fact, preclinical studies in human breast cancer xenografts have shown 
that using monoclonal antibodies (clone AIIB2) to block β1-subunits can reverse the 
malignant behavior of MCF-7 cells [50]. At the cell-matrix adhesions, integrins connect 
the matrix with the cytoskeletal network and transduce physical forces produced by the 
actin retrograde flow and actomyosin contractility to the ECM via mechanosensitive 
focal adhesion (FA) components known as ‘molecular clutch’ [45]. The molecular clutch 
senses ECM stiffness via mechanically induced protein conformational changes. On rigid 
matrix, high mechanical forces unfold talin to expose the vinculin-binding sites, which 
results in vinculin binding and clutch reinforcement. However, on complaint matrix, low 
mechanical forces on talin are insufficient to induce vinculin dependent force 
transmission [51]. The size of FAs ranges from 1-8 µm in length to less than 1 µm in 
breadth. Therefore each adhesion structures can sense the local properties of the 
heterogeneous matrix with sub cellular precision [52].     
During epithelial to mesenchymal transition (EMT), cancer cells can acquire 
increased migratory potential and the force transmission at the cell-cell adhesion is 
altered by down regulation of E-cadherin mediated adherens junction. Cadherin junctions 
are sensitive to mechanical loads and can exert a force of 4-5 nN/µm2 [53] that is similar 
to the force transmitted by integrin mediated cell-matrix adhesions (5.5 nN/µm2) [54]. 
Mechanical tension-induced conformational changes of α-catenin play an important role 
in controlling force transmission at the cadherin-catenin adhesion junctions. Indeed, α-
catenin serves as a mechanosensor by regulating force dependent binding with F-actin 
[55] and vinculin [56]. Cadherins and integrins are linked to the actin cytoskeleton and 
several studies suggest that mechanical tension driven crosstalk between them is essential 
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for force transduction [57]. Vinculin is one of the key molecules that are recruited to both 
the cell-matrix and cell-cell adhesion in a force-dependent manner and it facilitates the 
reinforcement of the junctions. Interestingly, vinculin is phosphorylated at different 
tyrosine residues at the respective adhesions. At the cadherins junctions, vinculin 
undergoes Abl kinases dependent phosphorylation at tyrosine 822 (Y822) [58], however, 
at the integrin junctions, Src kinase phosphorylates vinculin at Y100 and Y1065 [59]. 
Therefore, spatial regulation of vinculin phosphorylation plays a crucial role in 
determining its mechanical effect at the respective junctions. Apart from the integrin and 
cadherin receptors, several other mechanoreceptors such as G-protein coupled receptors, 
receptor tyrosine kinases, ion channels and glycocalyx have emerged recently [60]. 
Among them, the mechanosensitive transient receptor potential (TRP) channels have 
gained particular attention. Mechanical cues can activate the channels to cause calcium 
influx and actin reorganization [61]. 
 
2.2.2. Cytoskeletal components    
 
Within a three-dimensional matrix, cancer cells reorganize cytoskeletal elements 
such as actin, microtubules and intermediate filaments to adapt to the surrounding 
physical cues. Stress fiber is an important component of the cytoskeletal network and is 
composed of bundles of actin fibers cross-linked by α –actinin, fascin, filamin and zyxin. 
Non-muscle myosin II (NMMII) is often, but not always, present in the stress fibers and 
is responsible for generating contractile forces [62]. Stress fibers are also regarded as 
mesoscale mechanosensors because the tension within the stress fibers can be directly 
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transmitted to the matrix through the focal adhesions to generate isometric tension and 
such changes in tension helps the cell to sense surrounding forces [63]. Stiff matrix 
provides resistance to cellular contractility and increases proliferation by generating 
higher Rho-ROCK-Myosin based contractile forces, integrin clustering and ERK 
activation [25]. Recent studies have shown that the actin cytoskeleton could also act as a 
large-scale mechanosensor [44, 64]. As the matrix stiffness increases, the actin fibers 
tend to be more ordered and the number of stress fibers also increases [44, 65]. In 
addition to the organization of the fibers, the rheology of the actin could also be a 
possible mechanism for large-scale mechanosensing [44]. On complaint substrate, the 
actin fibers are not strongly attached to the substrate and this results in centripetal flow of 
actin towards the nucleus. In contrast, on stiff substrate, the stress fibers are more stable 
and anchored firmly to the matrix.  
  Microtubules are highly dynamic structures and undergo rapid remodeling by 
stochastic switching between polymerization and depolymerization phases. Previously, it 
was observed that microtubules prevented FA growth by suppressing contractility and 
localizing at the FA sites [66]. Microtubules provide specific tracks for the transport of 
cargoes to and from FAs. Moreover, MT1-MMP (membrane type 1 matrix 
metalloprotease) requires microtubules and kinesin motors for surface localization to 
facilitate matrix degradation [67]. Therefore, microtubules could favor the transport of 
MMPs to the FAs to degrade the interaction of integrins with the matrix and thereby 
inducing FA disassembly. There are few reports about the dynamics of intermediate 
filaments (IFs) in presence of mechanical cues and how it regulates FA assembly. In one 
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such study, it was observed that IF growth reduces FA turnover and mature fibrillar 
adhesions [68].  
 
2.2.3. Nuclear morphology and chromatin reorganization 
 
Nucleus is the largest and stiffest organelle in the cell and is subjected to 
considerable mechanical tension by the surrounding cytoskeleton during cancer cell 
division and invasion through the matrix. The nuclear envelope (NE) plays a crucial role 
in sensing mechanical cues and adapting the morphology and function of the nucleus. NE 
is a double membrane bound structure and associated with sub-nuclear structures such as 
the linker of the nucleoskeleton and cytoskeleton (LINC) complex, the nuclear pore 
complex (NPC) and the lamina. Spanning the NE is the LINC complex, which provides a 
direct physical connection between the cytoplasm and the nucleoplasm that could 
facilitate the transduction of mechanical cues from the ECM. During cell spreading on 
flat substrate, nuclear flattening occurs as the actomyosin fibers cover the top of the 
nucleus and exert compression forces on the NE and LINC complex [69]. However, 
during the early phases of cell spreading (<20 minutes), nuclear flattening might be 
caused by the change in cell shape independent of contractile forces [70]. The 
cytoskeletal network can regulate nuclear positioning within the cell during invasion 
through the matrix. The microtubule filaments exert shear stress on the NE, which results 
in nuclear rotation and translocation [71]. Contractile forces can also drive nuclear 
movement by either pushing or pulling the nucleus and enabling centrosome positioning 
[72].   
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Substrate geometry can regulate the cytoskeleton-mediated stresses and 
morphology of the nucleus. Two extreme geometries such as, the anisotropic rectangles 
and the isotropic circles were micro patterned on cell culture dishes. In rectangle shapes, 
cells develop strong stress fibers and a flattened nucleus. However, in circle patterns, 
short filaments of actin and a rounded nucleus was observed [73]. Apart from nuclear 
shape, the dynamics of the nucleus can be affected by the matrix geometry. On large 
isotropic patterns, nucleus show rotational dynamics, however, on small isotropic shapes, 
NE fluctuations were observed [74, 75]. Moreover, substrate geometry can also control 
the shuttling of the transcriptional cofactors between the nucleus and the cytoplasm and 
its interaction with the target genes in the 3D chromosome organization. For instance, on 
rectangular patterns, Chr3 was located in the interior of the nucleus whereas for circle 
patterns, it remained at the periphery of the nucleus [76]. This particular positioning was 
correlated with the higher expression of SRF/MRTF-A genes on this chromosome. 
Therefore, both 3D chromosome organization and nucleus to cytoplasmic shuttling of 
transcription factors can control epigenetics modifications in response to mechanical 
cues. 
 
2.2.4. Transcription factors shuttling between nucleus and cytosol 
  
Recent studies have observed that translocation of YAP/TAZ between nucleus 
and cytosol can serve as a key sensor of mechanical cues in the cancer microenvironment 
[77, 78]. When YAP enters the nucleus, it interacts with TEAD (TEA domain family 
member) transcription factor to regulate cell growth and apoptosis [79]. Cell density has 
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emerged as a crucial regulator of YAP/TAZ mediated signaling. In sparse cell density, 
YAP localizes in the nucleus to promote proliferation. However at higher density, YAP 
translocate predominantly in the cytosol to impose contact inhibition of proliferation 
(CIP) [80]. Interestingly, mechanical stretching of monolayer of cells at higher density 
promotes YAP entry into the nucleus to enhance proliferation of contact inhibited cells 
[13]. Therefore, physical forces can overcome growth arrest induced by CIP via 
mechanical activation of YAP. Matrix stiffness and geometry promotes regulated 
activation of YAP. When cells are cultured on a rigid matrix, they spread over a larger 
area with increased contractility and stress fiber formations, which leads to the activation 
of YAP. In contrast, on a soft matrix, cells are less spread and attain a rounded 
morphology with decreased actomyosin contraction, which inactivates YAP [81]. Cyclic 
stretching of cells on soft substrates can mimic that of a rigid matrix in promoting cell 
growth and stress fiber formation. Furthermore, on application of cyclic stretch, MRTF-A 
(myocardin-related transcription factor-A) translocate into the nucleus at a faster rate 
compared to YAP to enhance proliferation [82]. In order to undergo successful 
metastasis, cancer cells need to detach from the matrix and escape anoikis during their 
journey through the blood circulation. Cell adhesion to the matrix controls YAP activity. 
During cell attachment, YAP is activated whereas detached cell have inactivated YAP 
and undergoes anoikis [83]. Interestingly, expression of constitutively active YAP 
facilitates the survival of detached cells, implying that cancer cells with activated YAP 
can metastasize efficiently. Therefore, spatio-temporal activation of YAP in response to 
mechanical cues can overcome growth inhibition and anoikis induced by higher cell 
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density, soft substrates and matrix detachment, which could be crucial regulator of 
malignant growth.   
Apart from YAP/TAZ, various other transcription factors also shuttle between 
nucleus and cytosol in response to mechanical cues to maintain growth homeostasis. 
Fluid shear stress and compressive stress can induce the shuttling of NF-κB into the 
nucleus to regulate gene expression [84, 85]. Biaxial stretching of cells promotes nuclear 
ERK accumulation to promote survival [86]. Compressive stress can induce the 
translocation of armadillo (homologous to human β-catenin) into the nucleus to activate 
twist during early embryogenesis [87]. Nuclear G-actin and Rho-A signaling plays a key 
role in MRTF-A nuclear translocation and smooth muscle cell (SMC)-specific gene 
regulation [88]. In response to mechanical cues, focal adhesion protein Hic-5 induces 









Figure 2.2. Mechanisms of mechanotransduction. Cell surface receptors and ion 
channels: Cell senses the mechanical cues from the matrix such as stiffness, topography, 
stresses and mechanical stretching using the integrin receptors and focal adhesion 
complexes. At the cell-cell adhesions, cadherin-catenin mediated adherens junction plays 
a crucial role in controlling force transmission across a monolayer of cell sheet. 
Additionally, several other cell membrane bound mechanoreceptors such as G-protein 
coupled receptors (GPCR), receptor tyrosine kinases (RTKs) and ion channels helps in 
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sensing the mechanical niche. Cytoskeletal components: Stress fibers are an important 
component of the cytoskeletal network and are composed of bundles of actin fibers and 
non-muscle myosin II (NMMII) that generates contractile forces to sense the surrounding 
matrix. Nuclear dynamics and transcription factor shuttling: The nucleus is subjected to 
considerable mechanical tension by the surrounding cytoskeleton and it senses the 
mechanical cues via the LINC complex, 3D chromosome organization and nucleus to 
cytoplasmic shuttling of transcription factors such as YAP/TAZ, NF-κB. 
 
2.3. Recent technological advancements to study the effect of mechanical cues on 
cells and tissues  
2.3.1. Controlled microenvironment  
 
Recent years have observed collaborative efforts between biologists, tissue 
engineers and material scientists to develop advanced technologies and methodology to 
mimic cancer cell microenvironment in-vitro and to quantify crucial parameters [90-92]. 
Micropatterned substrates were used to define cell-cell and cell-matrix adhesions in a 
particular shape and confinement. Cell proliferation and apoptosis can be regulated by 
controlling the spreading area of the cell, which highlights the essence of mechanical 
cues in controlling cell fate [93]. Biomaterials that provides topographic cues can be 
fabricated with precise sub-micron scale architectures such as gratings, pillars and pores 
to control cell spreading area and positioning of cell surface receptors [94] (Fig 2.3.I). 
The techniques commonly used to fabricate such biomaterials include lithography [10], 
nanoimprinting [95], electrospinning [96], polymer dimixing [97]. Nanogratings 
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restricted the mobility and clustering of EPHA2 (EPH receptor A2) receptors expressed 
on the cell surface to regulate the downstream signaling events [98]. Micropillar arrays of 
sub-micron diameters are used to determine the forces exerted by the cell at the 
individual adhesion sites and to alter the rigidity of the substrate by changing the height 
of the pillars but maintaining diameter [54] (Fig 2.3.II). Recently, it was observed using 
micropillar arrays, that receptor tyrosine kinases such as AXL and ROR2 regulate the 
local contractions by the ‘pinching mechanism’ for rigidity sensing [99]. Moreover, 
microfluidic shear stress devices [12] and mechanical stretching instruments [82] have 
also been widely used to elucidate the complex mechanical coupling between the cell and 
its microenvironment. Alongside the mechanical cues from the ECM, the tumor 
microenvironment comprises a complex network of autocrine and paracrine secretion 
between the cancer cells and the non-cancerous stromal cells such as endothelial cells, 
fibroblasts, immune cells and mesenchymal stem cells (MSCs). Microfluidics technology 
has provided an opportunity to replicate such intricate cell-cell communications in-vitro 
with high spatio-temporal resolution and a dynamic three-dimensional 
microenvironment. The interaction between the cancer cells and the endothelial cells was 
mimicked in a microfluidic device during tumor extravasation and it was observed that in 
the presence of CXCL12 gradient, the tumor cells expressing CXCR4 receptors could 
transmigrate across the endothelial boundary [100]. The transition of mammary epithelial 
cells to their invasive phenotypes was studied by co-culturing cancer cells with 
fibroblasts in a 3D microfluidics device that provides a cost–effective solution to screen 
for the inhibitors of various pathways involved in this transition process [101]. The 
tumor-suppressing activity of interferon regulatory factor 8 (IRF-8) was studied by 
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culturing melanoma cells with immune cells and it was observed that the cancer cells 
acquired a greater malignant phenotype and migrated towards the IRF-8 knock out spleen 
cells compared to the wild type cells [102]. In another study using cell patterning and 
stable chemokine gradients, it was discovered that MSCs increase the invasiveness of 
tumor cells in the presence of CXCL12 gradient, which highlights the crucial interplay 
between MSCs and CXCL12–CXCR4 signaling during metastatic progression [103]. 
Latest advancements in tissue engineering, microfluidics and biomaterials have lead to 
the development of organ-on-a-chip and tumor-on-a-chip platforms that can precisely 
regulate organ scale complexity and 3D microenvironment under dynamic flow 
conditions [104]. The biochemical gradients within the tumor niche was replicated in a 
microfluidics device and the viable, apoptotic, and acidic regions of the tumor was 
monitored in real-time using time-lapse imaging [105]. Recently, a tumor-on-a-chip 
(TOC) device was engineered to better understand the trafficking of synthetic 
nanoparticles through the 3D tissue architecture in presence of fluid flow [106]. It was 
observed that the nanoparticles preferentially accumulate near the tissue periphery and 
selective receptor targeting enhances the penetration ability. Such devices could be 
developed for the screening of optimal nanoparticle dimensions before in-vivo studies. In 
another recent study, a TOC device was validated as a drug-screening platform and the 
differential migration of cancer spheroids and endothelial cells were monitored in 
presence of a morphogen gradient in a 3D niche [107].  
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2.3.2. Cellular mechanics  
  
Quantitative understanding of how cancer cells respond to the mechanical cues 
requires technologies that can apply controlled forces on the cells and simultaneously 
measure the cellular morphology and changes in molecular pathways. Micropipette 
aspiration can be used to determine the mechanical properties of single cells such as 
viscosity and elastic modulus by applying negative pressure to induce cell deformation 
and elongation into the pipette. The velocity at which the cell flows inside the 
micropipette under the application of a particular pressure is monitored. When cells at 
late cytokinesis were aspirated into the micropipette, myosin II is recruited in both the 
pipette and the furrow, which indicates the involvement of a mechanosensory system that 
direct contractile proteins to control shape changes during cell division [108]. Cancer 
cells are more deformable than healthy cells due to a disorganized and less filamentous 
cytoskeletal network as it helps the malignant cells to squeeze through the narrow 
constrictions of the ECM. Using microfluidic straight channels of specific dimensions, 
the deformability of healthy (MCF-10A) and non-metastatic (MCF-7) breast cancer cells 
were quantified in terms of cell transit time, cell velocity and cell deformation [109]. 
Recently, microfluidics based Deformability Cytometry (DC) was developed to quantify 
the deformability at a single cell resolution in real time to diagnose clinical pleural 
effusion samples as benign or malignant with 91% sensitivity [110] (Fig 2.3.III). 
Microfluidic optical stretchers are used to sequentially suspend, trap and deform isolated 
cells through a channel [111]. However, a major drawback of this system is that the force 
generated by the laser is not sufficient to cause enough deformation that a migrating cell 
Chapter 2: Literature review 
 
	 29	
encounters in-vivo [112]. While flowing through the circulatory system, the CTCs are 
exposed to various mechanical cues such as fluid shear stress (FSS) and confinement 
from the capillary walls. Using a microfluidic device to understand the effect of flow 
under micro-confinement, it was observed that cancer cells show dynamic responses to 
FSS when subjected to confinement of less than 70 µm [113]. Atomic force microscopy 
(AFM) is used to quantify the effect of cytoskeletal network and microenvironmental 
cues on the stiffness of the cells. AFM consists of a vertical cantilever with a probe that is 
used to deform the cell and forces are measured based on the deflection of the cantilever. 
Combination of AFM and fluorescence microscopy can be used to observe higher density 
of stress fibers in the regions of greater stiffness within a cell [114].  However, a major 
limitation of AFM is that the quantifications represent a collective behavior of many 
cytoskeletal elements and do not measure the contributions of individual structures within 
the cell. Subcellular laser ablation can overcome them, where a focused laser beam is 
used to irradiate nano or microscale structures within a live cell without affecting its 
viability. The mechanical properties of actomyosin stress fibers in endothelial cells that 
exert traction forces on the matrix during cancer angiogenesis was measured using laser 
ablation [115]. Magnetic tweezers can apply local stretching or bending forces in the 
range of 0.1–10 pN. Using this technique it was elucidated that talin serves as a 
mechanical buffer during matrix mediated force transduction via tension dependent 









In order to visualize submicron scale structures and dynamic interactions between 
protein domains in response to force, the development of fluorescence and super-
resolution microscopy techniques is of utmost importance. Fluorescence resonance 
energy transfer (FRET) can be used to quantify the distance and understand the 
interactions between two molecules. When the donor and the acceptor fluorophore (FP) 
are close enough (<10 nm) and in proper orientation, the excitation of the donor will 
transfer energy to induce emission of the acceptor. FRET biosensor has the donor and 
acceptor FP fused with a target molecule whose conformational dynamics are being 
monitored. Based on this concept, many single molecule biosensors are developed such 
as Ca2+ [117], cAMP [118], integrins [119], Rac1 [120]. Fluorescence recovery after 
photobleaching (FRAP) is used to quantify diffusion coefficient and mobile fraction of a 
target molecule inside the cell [121]. In this technique, the fluorescence intensity of a 
subcellular region is selectively photobleached and the recovery of fluorescence is 
observed at the same region over a period of time.  Other techniques used to monitor 
molecular mobility include fluorescence loss in photobleaching (FLIP) [122] and 
fluorescence correlation spectroscopy (FCS) [123]. In chromophore-activated light 
inactivation (CALI), the illumination of the FP can manipulate the function of the target 
protein inside the cell. For instance, on illumination, EGFP can disrupt α-actinin activity 
to cause disruption of stress fibers from the focal adhesions [124]. Recently, optogenetic 
tools have gained tremendous attention to regulate conformational changes and activation 
of proteins within the cells after light absorption [125]. Using such a tool to photo-
Chapter 2: Literature review 
 
	 31	
activate the endogenous formins within the cells, it was observed that increased F-actin 
polymerization along the stress fibers is not linked to greater myosin-II based 
contractility and increased focal adhesion size, which decouples the interplay between F-
actin content and contractility in stress fibers [126]. Several theoretical researches 
coupled with image analysis have been performed to model the force dependent growth 
of cell-matrix adhesions [127] and cytoskeletal reorganizations [44] in response to 
mechanical cues. Based on the assumptions that the stresses at the FAs are constant and 
the adhesions are elastic in nature, a model was proposed on the adsorption of proteins 
into an adhesion plaque that could predict substrate rigidity dependent regulation of FA 
size [128]. 
Light microscopy techniques have an optical resolution of 200-350 nm, which 
prevents it from distinguishing sub-domains of the protein in the nanometer scale. Super-
resolution techniques has been developed to overcome such limitations and to visualize 
macromolecular interactions in the range of 10-100 nm at the cell-cell [129] and cell-
matrix adhesions [130]. Photoactivated localization microscopy (PALM) and stochastic 
optical reconstruction microscopy (STORM) controls the number of FPs emitting 
simultaneously by using photoactivatable and photoswitchable FPs respectively. PALM 
was combined with interferometry (interferometric or iPALM) to elucidate the role of 
talin in organizing the vertical stratification of layers of protein in the focal adhesions 
[130]. Due to the long time required for such image acquisitions, there are few reports to 
investigate the dynamic adhesion proteins using PALM. The development of structured 
illumination microscopy (SIM) with image acquisition rates of around 1 second can be 
used to study protein dynamics in live cell, though at a lower resolution compared to 
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Figure 2.3. Technological advancements to study the effects of mechanical cues. 
Controlled microenvironment: (I) Micron scale topographic features with specific 
dimensions can be fabricated to mimic the architecture and orientation of the ECM in-
vivo. Microgratings provides anisotropic cues and cells preferentially align along the 
parallel direction of the grating axis. Reproduced with permission from [10]. Cells extend 
actin-rich protrusions such as invadopodia to sense the depth of the micropits. 
Reproduced with permission from [132]. (II) Micropillar arrays are used to vary the 
stiffness of the matrix by changing the height of the pillars at a constant diameter and to 
monitor the forces exerted by the cell at the individual adhesion sites. Cellular 
mechanics: (III) Schematic illustration of the microfluidic device made of PDMS 
(polydimethylsiloxane) showing single-cell mechanophenotyping. Cells are introduced 
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into the device under continuous flow and the deformability of the cells is measured in 
real-time and correlated to their malignance property (close up). Reproduced with 
permission from [133]. Imaging techniques: (IV) In order to image interior tissues in vivo 
using intravital microscopy, several optical window chambers have been established to 
optically access large areas without surgery. This includes the dorsal skin-fold chamber 
for investigating subcutaneous tumors, the cranial imaging window to study brain tumors, 
the abdominal imaging window to monitor intestine, pancreas and liver tumors and the 
mammary imaging window to visualize breast tumors. The mammary imaging window is 
used to image Dendra2-expressing breast tumor and the colour of around 100 cancer cells 
in highly vascularized region of the tumor were photoconverted from green to red using 
violet light. The locomotion of these cells was monitored over a period of time. It was 
observed that cancer cells with short hairpin RNA (shRNA)-mediated knockdown of 
neural Wiskott–Aldrich syndrome protein (N-WASP) that mediate actin reorganization, 
showed lesser movement away from the imaging site (bottom) compared to control 
shRNA cells (top). This indicates that N-WASP is required for the intravasation of cancer 
cells in the primary tumor. Scale bar 70 µm. Reproduced with permission from [134]. 
 
2.4. Mechanomedicine: Application of mechanobiology to medicine  
 
Mechanomedicine is an emerging interdisciplinary field that studies the 
application of mechanobiology principles to medicine for the betterment of cancer 
research and drug screening [135]. The central idea of this field of study is to translate the 
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knowledge from basic research into effective practical and clinical applications ranging 
from new therapeutics to improved diagnostics. CTCs in the circulatory system have 
great clinical potential for non-invasive liquid biopsy, as the number of CTCs in the 
cancer patients is known to correlate with the stages of cancer as well as the response of 
cancer therapies and treatments [136]. Currently, the CellSearch system is the only Food 
and Drug Administration (FDA) approved platform for CTC isolation from cancer 
patients, which uses epithelial cell adhesion molecules (EpCAM) coated particles to 
capture CTCs [137]. Label-free isolation of CTCs can overcome the limitations of 
antibody-based techniques such as loss of EpCAM-negative cancer cells, high cost and 
provides greater flexibility for single cell analysis and post-isolation culture. Using 
trapezoidal cross-section spiral microchannels, the CTCs are separated from the other 
blood cells based on their larger size at an ultra-high throughput of 7.5 mL in <10 min 
without affecting cell viability [138]. Tumor-on-a-chip platforms provide a great 
advantage to replicate the physiological multi-organ complexity in a 3D 
microenvironment for anti-cancer drug screening. To mimic the multi-organ interactions 
for in-vitro drug testing of Tegafur, an oral anti-cancer drug, colon cancer cell line (HCT-
116), hepatoma cell line (HepG2/C3A) and myeloblast cell line (Kasumi-1) representing 
the tumor, liver and marrow respectively were cultured in different interconnected 
compartments of a microfluidic device [139]. In another study, disease-on-a-chip 
platform was engineered to replicate portions of the mammary ducts and growth of 
cancer cells within healthy breast epithelium [140]. It was observed that the morphology 
of the cells cultured within this device is different compared to that grown on flat surface.  
  Research on cancer drugs requires high-throughput, cheap and consistent 
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screening methods to test new drug compounds. The advancement of microfluidics 
technology in handling minute volumes of reagents and rapid sample processing provides 
point-of-care (POC) testing and personalized cancer therapeutics. Using an integrated 
microfluidics platform for high content drug screening, the response of cancer cells to 
different anti-cancer drug gradient was monitored with greater accuracy and resolution 
[141]. In another study using droplet-based microfluidics to form tumor spheroids, it was 
observed that spheroids possess greater viability against anti-cancer drugs compared to 
the cells grown in monolayer [142]. Recently, a pipette-based microfluidic cell isolation 
(MCI) technology was developed to conduct single cell resolution drug assays with lesser 
number of tumor cells or their clusters and it was observed that CTC clusters are more 
resistant to chemotherapy drug doxorubicin [143]. Recent years have observed the 
development of mechano-inspired anticancer drugs that targets the components of the 
mechano-sensing and transduction signaling pathways such as the integrins, FAK (focal 
adhesion kinase), contractile machinery and transcription factors. These drugs are 
undergoing various clinical trails and are listed in Table 2.2. 
 
Table 2.2. List of drugs targeting mechanotransduction pathways in cancer 	
Drug name Molecular target Clinical trial References 
ATN-161 Integrin (α5β1) Phase II [144] 
Volociximab Integrin (α5β1) Phase II [145] 
NAMI-A Integrin (α5β1) - [146] 
Etaracizumab Integrin (α5β3) Phase II [147] 
Vitaxin Integrin (α5β3) Phase II [148] 
Cilengitide Integrin  
(α5β3, α5β5) 
Phase III [149] 
PF-562271 FAK and Pyk2 Phase I [150] 
VERSUS-6063 
VERSUS-4718 
FAK and Pyk2 Phase I [151] 
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Dasatinib Src Phase II [152] 
Verteporfin YAP - [153] 
Azidoblebbistatin Myosin II - [154] 
 
2.5. Summary and future perspectives 
We reviewed the influence of the mechanical cues from the cancer 
microenvironment on malignant growth, the mechanotranduction pathways involved in 
causing phenotypic changes and the technological advancements to quantify important 
parameters. There are urgent needs to reproduce the mechanical complexity of the in-vivo 
microenvironment under controlled laboratory experimental conditions for applications 
such as anti-cancer drug evaluation and the development of mechanobio-based 
therapeutic strategies. The development of patient-derived xenograft (PDX) models 
[155], 3D organoid systems [156], purification, enrichment and in-vitro culture of 
clinical samples such as circulating tumor cells (CTCs) [157, 158], graphene based 
materials [159] and single-cell profiling approaches [160] have delivered invaluable 
translational resources for personalized treatment of cancer patients. Additionally, the 
advent of ‘tumor-on-a-chip’ [106] and ‘human-on-a-chip’ [161] microfluidic platforms 
that offers integrated and inter-connected compartments mimicking different organs of 
the body provides a physiologically relevant pharmacokinetic model. Microscopic 
advancements such as single-objective selective-plane illumination microscopy (soSPIM) 
[162], intravital microscopy [163] (Fig 2.3.IV), positively photoswitchable fluorescent 
proteins [164] and optogenetic tools [126] to visualize single molecules and dynamic 
mechanobiological processes with higher spatio-temporal resolution in cells and animal 
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models are emerging. We foresee increasingly exciting prospects in the field of 
mechanopathology where more potential targets can be identified and their molecular 
bases delineated for the development of new and more effective drugs. These new family 
of drugs, when used either singly or in combinations with other conventional drugs, could 
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Chapter 3 
Topography induces differential sensitivity on cancer 
cell proliferation via Rho-ROCK-Myosin contractility 
 
In this chapter, I will present the experimental evidences to understand the role of 
topographic cues of the primary breast tumor microenvironment on the proliferation 
ability of healthy and cancer cells. Following that, I will present the results to elucidate 
the crucial role of actomyosin contractility in regulating the mechanotranduction of 
















Blood borne metastasis from the primary tumor to the specific secondary location 
is the major cause of cancer related deaths. Several soluble factors secreted by the 
stromal cells of the cancer microenvironment are known to contribute to the specificity of 
the secondary niche [4, 165]. However, it is less understood whether the mechanical cues 
within the metastatic niche such as matrix stiffness, topography and physical stresses are 
responsible for controlling the proliferation and colonization efficiency of the cancer 
cells.  
 The architecture and orientation of the collagen fibers of the primary breast 
tumor microenvironment undergoes dynamic reorganization during the progression of the 
metastatic disease (tumor-associated collagen signature (TACS)) [166, 167]. During 
healthy conditions, the collagen fibers are arranged in a random, isotropic orientation 
(TACS-1). However, during tumor progression, the fiber undergoes organized and 
anisotropic arrangement (TACS-3) [28]. This particular anisotropic orientation of the 
ECM fibers promote cell adhesion along the fibers and the cancer cells use these aligned 
fibers as ‘highways’ to metastasize away from the primary tumor with greater directional 
persistence and displacement [29, 168]. Using pharmaceutical inhibitors targeting rho-
associated, coiled-coil containing protein kinase (ROCK) and myosin light chain kinase 
(MLCK), it was observed that the migration of metastatic breast cancer cells, MDA-MB-
231, along the organized collagen fiber depends on actomyosin contractility but not on 
MLCK signaling [169]. Although the above studies observed the importance of 
topographic cues on cancer cell migration, little is understood about the role of 




topographic cues in regulating cancer cell proliferation. In this chapter, I will delineate 
the effect of topographic cues on cancer cell proliferation using micron scale topographic 
features such as, gratings and pillars of specific dimensions. Subsequently, I will discuss 
the role of actomyosin contractility in regulating the mechanotranduction of topographic 
cues and affecting cancer cell proliferation. In conclusion, I will introduce the concept of 
Mechanically-Induced Dormancy (MID), where anisotropic topographic cues could 
inhibit the proliferation of normal cells via activation of Rho-ROCK-Myosin pathway but 
the cancerous cells could somehow by-pass such growth inhibitory barrier and continue 
their uncontrolled proliferation. 
 
3.2. Methods 
3.2.1. Fabrication of topographic patterns  
Different topographic patterns were fabricated using SU-8 on silicon wafers. The 
dimension of each pattern was 1x1 cm. The surrounding unpatterned region outside the 
topographic patterns was used as planar control. Curing agent : polydimethylsiloxane 
(PDMS; Sylgard 184, Dow Corning) of 1 : 10 ratio was mixed homogenously and poured 
on silanized silicon wafer. Degassing was done to remove all air bubbles formed during 
mixing. After degassing, PDMS was cured for 2 hours at 80ᴼC. Cured PDMS was peeled 
off from the silicon wafer and subsequently used for cell seeding. To validate the 
successful replication of different topographic patterns, PDMS substrates were sputter-




coated with 11-nm-thick platinum (JEOL JFC 1600 Auto Fine Coater) and imaged with 




Figure 3.1. Scanning electron microscopy (SEM) of different topographic patterns 











Table 3.1. Dimension of grating patterns  
 
No. Width (µm) Space (µm) Height (µm) 
1 2 2 8 
2 3 3 8 
3 4 4 8 
 
Table 3.2. Dimension of pillar patterns  
 
No. Pillar diameter  
(µm) 




1 2 4 2 
2 3 6 2 
3 4 8 2 	
 
3.2.2. Cell culture  
Non-cancer human breast epithelial cells (MCF-10A; American Type Culture 
Collection (ATCC)) were cultured in mammary epithelial growth medium (MEGM 
Bullet Kit; Lonza Corporation), supplemented with cholera toxin (100 ng mL-1). Prior to 
cell seeding on topographic patterns, cells were synchronized in the G0 / G1 phase by 
growing cells to 100% confluence for 1 to 3 days in the same medium [170]. 




Synchronized cells were then trypsinized and seeded on the patterns. The culture of 
human metastatic breast cancer cell line (MDA-MB-231; ATCC) and human non-
metastatic breast cancer cell line (MCF-7; ATCC) was carried out in DMEM 
supplemented with 10% fetal bovine serum, 1% penicillin and streptomycin at 37ᴼC in 
5% CO2 environment. Cells were trypsinised on reaching 80% confluence. Prior to 
seeding on the patterns, the cells were serum starved overnight to synchronize the cell 
cycle.  
The PDMS patterns were cleaned, air-plasma treated for 3 minutes (Model PDC-
002, Harrick Scientific Corp) and sterilized with 70% isopropanol and UV for 5 minutes. 
They were subsequently coated with 10 µg ml-1 fibronectin (Sigma-Aldrich), 20 µg ml-1 
collagen I (Bovine; Nutragen) or 20 µg ml-1 laminin (from Engelbreth–Holm–Swarm 
murine sarcoma; Invitrogen) for 1 hour at 37ᴼC. Excess protein was then washed away 
prior to cell seeding. 70,000 cells per pattern were seeded to maintain 70% confluence. 
The cells were cultured on the patterns for different periods of time ranging from 6 hours 
to 72 hours, as mentioned in the text.  
 
3.2.3. Cell proliferation and apoptosis assay  
After culturing the cells on the patterns, the cells were washed with 1X phosphate 
buffered saline (PBS, Sigma Aldrich) and subsequently fixed with 4% (w⁄v) 
paraformaldehyde (PFA, Sigma Aldrich) for 20 minutes. 0.01% Triton X‐100 was used 
for 10 minutes to permeabilize the cells. Proliferating cells were identified using EdU 
staining from Click-iT™ EdU Alexa Fluor® 555 Imaging Kit (Invitrogen, C10338). The 




nucleus of the cells was labeled with DAPI stain (Invitrogen, D1306) and were imaged 
using Nikon Confocal A1R microscope. Proliferating cells (stained with EdU) and total 
number of cells (stained with DAPI) were manually counted and ratio between them was 
done to obtain the percentage of proliferating cells. For each experiment, 300 cells were 
considered on an average. In order to identify apoptotic cells, cells were cultured in 
presence of 2 µM NucViewTM 530 Caspase-3 Substrate for 24 hours and then washed 
with 1X PBS and fixed using 4% PFA. The nucleus of the cells was stained with DAPI 
and fluorescent microscopy was performed. 
 
3.2.4. Inhibitor drug treatment 
To perform drug inhibitor experiments, different concentrations (5 µM, 10 µM, 20 
µM) of Blebbistatin (non-muscle Myosin II inhibitor; Sigma-Aldrich) and different 
concentrations (1 µM, 5 µM, 10 µM) of Y-27632 (ROCK inhibitor; Sigma-Aldrich) was 
added to the cell culture media 6 hours after cell seeding, to allow the cells to adhere and 
spread properly. The cells were cultured in presence of the inhibitory drugs for 18 hours 
and the media was replenished with fresh media containing same concentration of drug 
once after 9 hours, to avoid any confounding effect due to inactivation of the drug during 
the long incubation time period.     
 
3.2.5. Quantification of cell spreading and alignment 
Samples were fixed using 4% PFA and permeabilized with 0.01% Triton X‐100. 
F-actin was stained using Green 488 phalloidin (Invitrogen) and the nucleus was labeled 




with DAPI. Samples were washed thrice with 1X PBS and imaged using Nikon Confocal 
A1R microscope. Cell boundary was traced manually using ImageJ to measure cell area 
and angle. Alignment of cells was considered if the angle between the major axis of the 
cell and the grating was less than 15°. The alignment percentage of the cells was 
determined and for each experiment 200 cells were considered on an average.  
 
3.2.6. Western blot analyses 
Cell lysates were separated by gradient SDS-PAGE gels (Biorad) followed by 
western blotting with 1 hour of blocking (5% BSA in 0.1% Tween in TBS) at room 
temperature (R.T), overnight primary antibody incubation at 4°C, and 3 washes of 10 
minutes each at R.T. Blots were then incubated with secondary antibody for 1 hour at R.T 
and final 3 washes of 10 minutes each at R.T. Immunoblots were developed using Pierce 
Pico ECL (Thermo Scientific). Antibodies used were polyclonal phospho-MLC of 
Thr18/Ser19 (CST), polyclonal MLC (CST) and monoclonal α-tubulin (Sigma).  
 
3.2.7. Statistics 
Student’s t-test was done for statistical analysis. Each experiment was repeated at 
least thrice. Data represents ± s.e.m (standard error of mean) for independent experiments 
(n=3). Statistical significance was considered at p <0.05 and p <0.01. All statistical 
comparisons were based on experiments performed on the same day.  
 




3.3. Results and discussion 
3.3.1. Microgratings decreases proliferation of non-cancer epithelial (MCF-10A) but 
not of malignant breast cancer cells (MCF-7, MDA-MB-231) 
  
The basement membrane matrix consists of topographic features such as, fibers, 
ridges and pores in the sub-micron scale [171]. To better mimic the topographic cues in-
vivo, we fabricated micro-topographic features: gratings and pillars of specific 
dimensions that have been previously observed to affect various cellular functions 
including proliferation [172, 173], differentiation [174, 175], and migration [95, 176] by 
regulating the localization of cell surface receptors and cytoskeleton reorganizations. 
Microgratings provide anisotropic cues to the cells thereby leading to preferential 
alignment in parallel direction to the grating axis [177]. In contrast, micropillars provide 
isotropic cues to the cells and promotes random morphology [94]. To confirm the 
reproducibility of our findings for a particular topographic feature, we fabricated three 
different gratings widths of 2, 3 and 4 µm (Table 3.1.), and three different diameters of 
micropillars at 2, 3 and 4 µm, (Table 3.2.) respectively. PDMS stiffness was kept 
constant across different topographic patterns by maintaining a constant base to cross-
linker ratio of 10:1 that has a Young's modulus of 580 kPa [178]. To negate the effect of 
rigidity change, a similar aspect ratio was maintained across the different diameters of the 
pillars. Scanning electron micrograph (SEM) was performed to validate the successful 
replication of different features as illustrated in Fig. 3.1.             




To elucidate the role of topographic cues on cancer cell proliferation, MCF-10A 
and MDA-MB-231 cells were cultured for 24 hours on collagen-coated microgratings. 
The collagen coating did not obstruct the topographic cues from the microgratings, as 
observed in previous report [95]. The proliferation of MCF-10A decreased on different 
dimensions of microgratings compared to the planar control and the greatest reduction 
was observed for 3 µm gratings (Fig. 3.2a.). It is believed that the 3 µm gratings might 
have provided an optimal dimension of topographical cue for the cell surface receptors to 
reorganize the cellular cytoskeleton and reduce cell proliferation. To understand whether 
cell-cell adhesion or/and cell-matrix interaction plays a key role in reducing MCF-10A 
proliferation on microgratings, cells were seeded at sparse density (Fig. 3.3.). 
Interestingly, we observed that microgratings reduces MCF-10A proliferation even at 
lower cell density, which signifies the importance of cell-matrix interactions in reducing 
MCF-10A proliferation by microgratings. To determine if MCF-10A cells seeded on 
microgratings are undergoing apoptosis, we stained the cells for caspase activity and 
observed no significant difference in apoptosis between the cells grown on planar and 
microgratings (Fig. 3.4.). Therefore, microgratings induce MCF-10A cells to enter a 
dormant state after 24 hours of culture.  
 






Figure 3.2. Microgratings reduces proliferation of non-cancer epithelial but not of 
metastatic breast cancer cells. a. MCF-10A proliferation decreases on different 
dimensions of collagen-coated microgratings after 24 hours of cell seeding. Data are 
means ±s.e.m. (n=3). For each experiment, 300 cells were considered on an average. ** p 
< 0.01 with respect to planar. b. Topographical cues do not affect MDA-MB-231 
proliferation. N.S, non-Significant with respect to planar. c. Confocal microscopy 
representative images of proliferating MCF-10A and MDA-MB-231 cells cultured on 
different topographic patterns; DAPI: Blue, EdU: Red. Double-sided arrow indicates the 
direction of the grating axis. (Scale 50 µm) 






Figure 3.3. Microgratings reduces MCF-10A proliferation at sparse density. a. 
Confocal microscopy images of proliferating MCF-10A cells cultured on 2 µm 
microgratings; DAPI: Blue, EdU: Red (Scale 100 µm). Double-sided arrow indicates the 
direction of the grating axis. b. Percentage of proliferating MCF-10A cells. Data are 
means ±s.e.m. (n=3). For each experiment, 300 cells were considered on an average. ** p 
< 0.01 with respect to planar.   
 





Figure 3.4. Microgratings do not lead to apoptosis of MCF-10A cells. a. Percentage of 
apoptotic MCF-10A cells. No significant difference in apoptosis between cells grown on 
planar and 2 µm microgratings. Data are means ±s.e.m. (n=3). For each experiment, 200 
cells were considered on an average. N.S. denotes non-significant difference compared to 
planar. b. Confocal microscopy representative images of apoptotic cells (arrow). Double-
sided arrow indicates the direction of the grating axis. (Scale 50 µm) 
 
In contrast to MCF-10A cells, there was no significant change in MDA-MB-231 
proliferation rate across the different gratings. This indicates that topographical cues 
reduce proliferation of only the normal epithelial but not that of metastatic breast cancer 




cells (Fig. 3.2b). Confocal microscopy images of cells grown on different micrograting 
dimensions were shown in Fig. 3.2c, where nucleus of all the cells was labeled with 
DAPI (indicated in blue) and proliferating nucleus was stained with EdU (indicated in 
red). Furthermore, different pillar dimensions did not affect the proliferation of MDA-
MB-231 (Fig. 3.5.). Similarly, topographic features did not affect MCF-7 proliferation 
across different matrix proteins such as, fibronectin, collagen and laminin after 24 hours 
of cell seeding (Fig. 3.6.). Therefore, the malignant cancer cells have some intrinsic 










Figure 3.5. Different pillar diameters do not affect MDA-MB-231 cell proliferation. 
Data are means ±s.e.m. (n=3). For each experiment, 300 cells were considered on an 
average. N.S. denotes non-significant difference compared to planar. 





Figure 3.6. Topographic features do not affect MCF-7 proliferation across different 
ECM proteins after 24 hours of cell seeding. Cells were seeded on 2 µm microgratings 
and 2 µm micropillars. Data are means ±s.e.m. (n=3). For each experiment, 300 cells 









3.3.2. Microgratings induces greatest reduction in proliferation of MCF-10A cells 
for collagen coating after 24 hours of cell seeding 
 
To understand whether micrograting-induced proliferation reduction of MCF-10A 
is dependent on the ECM composition, we seeded cells on microgratings coated with 
various matrix proteins namely, fibronectin, collagen and laminin, all of which are found 
to be present in the cancer microenvironment. Interestingly, the proliferation of MCF-
10A decreases across all the three ECM proteins after 24 hours of cell seeding (Fig. 
3.7a). This indicates that topographical cues dominate over the biochemical cues 
provided by the different ECM matrix in reducing MCF-10A proliferation. The greatest 
reduction in proliferation of 0.48 fold was observed for collagen coating (Fig. 3.7b). 
Collagen is one of the most abundant ECM proteins in the cancer stroma and it 
contributes significantly to maintaining the tensile strength of the tissue [179]. Therefore, 
when cells are seeded on microgratings patterns, cell surface receptors might sense the 
specific chemical and physical cues associated with collagen matrix thereby leading to 
the greatest reduction in proliferation. Collagen-coated microgratings might trigger 
mechanotransduction signaling pathways involved in the reduction in cell proliferation 
either in an integrin dependent manner (through the activation of integrin receptor 
subunits β1, α1, α2, α10 or α11) [180] or in an integrin independent manner (via the 
activation of Discoidin Domain Receptors (DDRs), a sub family of tyrosine kinase 
receptors) [181]. This might activate the tyrosine phosphorylation pathways involving 




Src and Focal Adhesion Kinases (FAK), which could lead to the reorganization of 




Figure 3.7. Microgratings induces greatest reduction in proliferation of MCF-10A 
cells for collagen coating after 24 hours of cell seeding. a. MCF-10A proliferation was 
reduced by 2 µm microgratings across all the extracellular matrix (ECM) proteins, such 
as, fibronectin, collagen, laminin after 24 hours of cell seeding. Microgratings was coated 
with ECM proteins to facilitate cell adhesion, spreading and proliferation. b. Greatest 
reduction in proliferation was observed for collagen coating. c. Maximum reduction in 




proliferation occurred for collagen coating after 24 hours of cell seeding (indicated by red 
box). Blue and red colored line indicates the growth curve of cells seeded on planar and 2 
µm microgratings, respectively. Data are means ±s.e.m. (n=3). For each experiment, 300 
cells were considered on an average. ** p < 0.01 and * p < 0.05 with respect to planar. d. 
Fold change calculation in proliferating cells as a function of time. * p < 0.05 
 
Subsequently, we characterized the temporal dynamics of micrograting-induced 
dormancy of MCF-10A cells by culturing cells on collagen coated microgratings for 
different periods of time (Fig. 3.7c). Representative confocal microscopy images of the 
morphology of MCF-10A cells seeded on 2 µm microgratings at various time points are 
shown in Fig. 3.8. The proliferation of cells on microgratings decreased at all time points 
starting from 12 hours to 72 hours after cell seeding. Therefore, cells need at least 12 
hours to transduce the topographical cues from microgratings and thereafter reducing 
proliferation. Interestingly, the greatest reduction in proliferation of 0.5 fold was 
observed after 24 hours of cell seeding (Fig. 3.7d). The doubling time of MCF-10A is 
approximately 20 hours on normal tissue culture dishes [182]. However, the proliferation 
fold change tends to increase gradually over the subsequent time points from 36 to 72 
hours, which suggests that cells tend to recover and develop resistance from the 
topography induced temporary dormancy with the passage of time.  
 






Figure 3.8.  Confocal microscopy representative images of the morphology of MCF-
10A cells seeded on 2 µm microgratings for various time points. Double-sided arrow 
indicates the direction of the grating axis (Phalloidin: Green; DAPI: Blue; Scale 50 µm).  
 
3.3.3. Microgratings reduces MCF-10A proliferation through the activation of Rho-
ROCK-Myosin pathway 
 
Then we questioned whether the anisotropic cue provided by the microgratings is 
responsible for the reduction in MCF-10A proliferation. To answer this question, we 
sought to eliminate the anisotropy from microgratings by fabricating lines in 
perpendicular direction to the grating axis to create isotropic pillar patterns (Fig. 3.9a). 
MCF-10A was cultured for 24 hours on collagen-coated microgratings and micropillars 
of three different diameters, namely, 2, 3 and 4 µm as mentioned earlier. Interestingly, 
MCF-10A proliferation decreased on microgratings but not on micropillars of different 




topographic dimensions (Fig. 3.9b), signifying the importance of anisotropic cues for the 




Figure 3.9. Microgratings reduces MCF-10A proliferation through the activation of 
Rho-ROCK-Myosin pathway. a. Schematic representation of the morphology of cells 
seeded on anisotropic (gratings) and isotropic (pillars) patterns. b. MCF-10A 
proliferation decreased on microgratings but not on micropillars of different diameters. 
Acto-myosin contractility plays a crucial role in the reduction of proliferation of MCF-
10A cells on microgratings. Acto-Myosin contraction inhibitory drug treatment: c. 




Blebbistatin (5 µM, 10 µM, 20 µM), d. Y-27632 (1 µM, 5 µM, 10 µM), e. Time course of 
cell proliferation after treatment with acto-myosin contraction inhibitory drug Y-27632 (5 
µM) for various time points. Blue bar indicates planar and red indicates 2 µm 
microgratings. Data are means ±s.e.m. (n=3). For each experiment, 300 cells were 
considered on an average. ** p < 0.01 with respect to planar. N.S. denotes non-significant 
difference compared to planar. 
 
Next, we hypothesized that the topography-induced temporary dormancy of 
MCF-10A cells could be due to the generation of micrograting-mediated higher 
actomyosin contractility within the cell. To test this hypothesis, we treated MCF-10A 
cells cultured on microgratings with different concentrations of actomyosin contraction 
inhibitory drugs namely, blebbistatin (non-muscle myosin II inhibitor) (5 µM, 10 µM, 20 
µM) (Fig. 3.9c), Y-27632 (ROCK inhibitor) (1 µM, 5 µM, 10 µM) (Fig. 3.9d) and for 
different periods of time (12, 24, 48 hours) (Fig. 3.9e). Previous studies have found that 
the concentration of drugs used here are sufficient to inhibit the protein expression of the 
respective drug targets and cause filopodial structure formation [183, 184]. Inhibition of 
actomyosin contraction prevented reduction in micrograting-mediated proliferation 
across the different concentrations and different time period of the drug used. In other 
words, in the presence of actomyosin contractility inhibitory drugs, cells are unable to 
distinguish between planar and microgratings, which suggests the involvement of Rho-
ROCK-Myosin based contractility in sensing topographic cues and reducing 
proliferation. Interestingly, cells plated on microgratings expressed less amount of 




myosin light chain (MLC) when compared to those cultured on the planar ones. 
However, they exhibited higher level of active and phosphorylated form of MLC when 
normalized to the total pool present in the cells (Fig. 3.10.). This result is consistent with 
the notion that despite reducing amount of myosin (probably owing to a yet unknown 
feedback mechanism), microgratings could activate Rho/ROCK/Myosin pathway. Our 
findings also support the previous report that microscale protrusions (‘micropegs’) 
reduced cell proliferation in fibroblasts and myoblasts through the generation of acto-
myosin contractile forces [185]. Together, these studies highlight the significance of acto-
myosin contractility-based signaling events in sensing mechanical cues from the cellular 
microenvironment and leading to the reduction in cell proliferation. However, it was 
unclear whether microscale protrusions lead to permanent or temporary reduction in 
fibroblasts and myoblasts cell proliferation. Our study therefore demonstrates the 
importance of anisotropic cues in the induction of topography-mediated reduction in cell 
proliferation that leads to temporary dormancy.  
 






Figure 3.10. Lysates from MCF-10A cells grown on planar (PL) or microgratings 
(MG) were separated by gradient gel and immunoblotted (IB) with antibodies for 
phospho-MLC (pMLC), MLC and α-tubulin as loading control. 
 
3.3.4. Microgratings reduces spreading area in MCF-10A but not in MDA-MB-231 
cells 
 
To examine whether the topography-induced temporary dormancy of MCF-10A 
is related to cell spreading, we cultured MCF-10A and MDA-MB-231 cells on collagen 
coated microgratings patterns for 24 hours and then stained for the F-actin cytoskeleton 
with phalloidin. Representative confocal microscopy images are shown in Fig. 3.11a. 




The spreading area of MCF-10A cells on microgratings decreased gradually with respect 
to the planar control as the grating width increased from 2 µm to 4 µm (Fig. 3.11b). 
Interestingly, microgratings did not significantly reduce MCF-10A cell spreading area 
after 24 hours treatment of acto-myosin contraction inhibitory drug Y-27632 (5 µM) (Fig. 
3.12), which signifies that microgratings induces activation of Rho-ROCK-Myosin based 
higher contractile forces that decreases MCF-10A cell spreading area and proliferation. 
However, microgratings did not reduce MCF-10A cell spreading area after 6 hours of cell 
seeding (Fig. 3.13), consistent with the previous indication that at least 12 hours are 
required for the transduction of topographical cues. In contrast, MDA-MB-231 cell 
spreading area increased on microgratings compared to planar surface (Fig. 3.11c). 
Higher invasive and metastatic potential of MDA-MB-231 cells might be responsible for 
this as they tend to follow the pathway of least resistance parallel to the grating where 
they could adhere and spread more, thereby resulting in more efficient and persistent 
migration, as was observed in [169]. Interestingly, both MCF-10A (Fig. 3.11d) and 
MDA-MB-231 (Fig. 3.11e) tend to align preferentially along the grating axis and MDA-
MB-231 shows a remarkable higher alignment percentage of around 99% as evident from 
the confocal microscopy images as well and this finding is consistent with previous 
report [30]. We believe that parallel axis of the grating provides more regions for cellular 
adhesion and therefore, the cells need to overcome lesser barrier while migrating along 
the gratings.  
 






Figure 3.11. Microgratings reduces spreading area in MCF-10A but not in MDA-
MB-231 cells. a. Confocal microscopy representative images of the morphology of 
MCF-10A and MDA-MB-231 cells seeded on various topographic patterns. Double-sided 
arrow indicates the direction of the grating axis. (Phalloidin: Green; DAPI: Blue; Scale 
50 µm). Spreading area of b. MCF-10A cells and c. MDA-MB-231 cells across various 
dimensions of microgratings. Spreading area decreases for MCF-10A but increases for 
MDA-MB-231 cells on microgratings. Alignment percentage of d. MCF-10A cells and e. 
MDA-MB-231 cells along the gratings. Both cells are aligned parallel to the 




microgratings. Data are means ± s.e.m. (n=3). For each experiment, 200 cells were 
considered on an average. ** p < 0.01 and * p < 0.05 with respect to planar. 
 
 
Figure 3.12. Microgratings does not reduce MCF-10A cell spreading area after 24 
hours treatment of acto-myosin contraction inhibitory drug Y-27632 (5 µM). Data 
are means ±s.e.m. (n=3). For each experiment, 200 cells were considered on an average. 
N.S. denotes non-significant difference compared to planar. 
 






Figure 3.13. Microgratings does not reduce MCF-10A cell spreading area after 6 
hours of cell seeding. Data are means ±s.e.m. (n=3). For each experiment, 200 cells were 
considered on an average. N.S. denotes non-significant difference compared to planar. 
 
However, confocal microscopy images (Fig. 3.14a) of cells grown on different 
diameters of micropillars indicate that micropillars reduce the spreading area for both 
MCF-10A (Fig. 3.14b) and MDA-MB-231 (Fig. 3.14c) cells. This is due to the limited 
area of cell attachment on top of the pillars whereas on a planar surface, there is a larger 
continuous surface for cell adhesion. Additionally, there was no preferential alignment of 
MCF-10A (Fig. 3.14d) and MDA-MB-231 (Fig. 3.14e) cells along any direction. This 




result is consistent with the notion that the pillar provides an isotropic environment and as 




Figure 3.14. Micropillars reduces spreading area of both MCF-10A and MDA-MB-
231 cells. a. Confocal microscopy representative images of the morphology of MCF-10A 
and MDA-MB-231 cells seeded on various topographic patterns. (Phalloidin: Green; 
DAPI: Blue; Scale 50 µm). Spreading area of b. MCF-10A cells and c. MDA-MB-231 
cells across various diameters of micropillars. Spreading area decreases for both MCF-
10A and MDA-MB-231 cells. Alignment percentage of d. MCF-10A cells and e. MDA-




MB-231 cells along the pillars. No significant alignment of cells was observed. Data are 
means ±s.e.m. (n=3). For each experiment, 200 cells were considered on an average. * p 




Figure 3.15. Schematic representation of Mechanically-Induced Dormancy (MID). 
The anisotropic topographical cues provided by microgratings could reduce the 
proliferation of MCF-10A cells and induce a temporary dormancy. However, MDA-MB-
231 and MCF-7 cells could successfully overcome this temporary dormancy barrier and 
continue uncontrolled proliferation. Interestingly, treatment with acto-myosin contraction 
inhibitory drugs prevented topography induced temporary dormancy of MCF-10A, which 
suggests the involvement of Rho-ROCK-Myosin based contractility in sensing 
topographic cues and reducing proliferation.  
 





In summary, we have unraveled a previously unknown proliferation inhibitory 
effect of mechanical cues (Mechanically-Induced Dormancy; MID) that exerts temporary 
dormancy in the normal epithelial cells but somehow the malignant cells could overcome 
such barrier and grow unaffected (Fig. 3.15.). The desmoplastic ECM is dynamically 
remodeled in a highly organized and anisotropic manner by the activation of stromal cell 
in the tumor microenvironment [28]. The cancer cells utilize this anisotropy to their own 
benefit by using the aligned collagen fibers as ‘highways’ to migrate away from the 
primary tumor in a more efficient and persistent manner [186]. But it was not known 
previously what role this anisotropic environment has on the proliferation efficiency of 
the cancer cells. We mimicked this anisotropic topography in-vitro by fabricating 
microgratings of different dimensions using micro-fabrication. We observed that the 
anisotropic topographical cues could reduce the proliferation of MCF-10A and induce a 
temporary dormancy. However, MDA-MB-231 and MCF-7 cells could successfully 
overcome this temporary dormancy barrier. Interestingly, treatment with Y-27632 and 
blebbistatin prevented topography induced temporary dormancy of MCF-10A, which 
suggests the involvement of Rho-ROCK-Myosin based contractility in sensing 
topographic cues and reducing proliferation. However, the proliferation of different 
mesenchymal cells such as human fore skin fibroblast reduces on nano-gratings [187] and 
that of human bladder epithelial cells (T24) shows no effect on micro-gratings [188]. This 
indicates that the effect of topographical cues on the proliferation of the cells is 
dependent on the intrinsic properties of the individual cell types, rather than on the 




epithelial or mesenchymal phenotypes. This study highlights the importance of 
mechanical (topographical) cues in maintaining normal tissue homeostasis during healthy 
conditions. However, during diseased condition (cancer outgrowth), this proliferation 
inhibitory mechanical cue fails to provide a barrier and this might be one of the reasons 
for the uncontrolled proliferation of cancer cells.  
	 70		 		 		
Chapter 4 
Differential depth sensing reduces cancer cell 
proliferation via Rho-Rac regulated invadopodia 
  
In the previous chapter I have presented how the anisotropic topographic cues of 
the primary breast tumor microenvironment affect the proliferation of healthy and cancer 
cells via activation of actomyosin contractility. During the course of the metastatic 
progression, the cancer cells spread from the primary tumor through the circulatory 
system and bone is one of the principal secondary niches for breast cancer metastasis. In 
this chapter, I will mimic the porous microenvironment of the bone using 
microfabrication technology and present experimental evidences on how the cells sense 
the depth of the pores using actin rich protrusions such as invadopodia to regulate their 
proliferation. Following that, I will discuss the differential regulation of actomyosin 
contractility in response to depth sensing cues between the healthy and the cancer cells, 












Blood borne metastasis of cancer cells from a primary tumor to a secondary 
location is one of the leading causes of cancer-related deaths worldwide. The 
disseminated tumor cells (DTCs) that are principally found in the secondary locations 
such as bone marrows either stop their proliferation ability due to the hostile 
microenvironment and enter a temporary dormancy for an indefinite period or they grow 
slowly into a micro-metastases as the amount of cell death counter-balances proliferation 
rate [1]. Therefore, the microenvironment that surrounds the tumor cells in their 
secondary niche plays a decisive role in determining the final fate of the metastatic 
disease. Over the last decade, it has increasingly been observed that mechanical cues 
from the microenvironment such as topography [10], stiffness [25] and shear stress from 
the circulatory system [12] can influence the phenotypic behavior of healthy and cancer 
cells. However, it is not yet understood what are the roles of the mechanical cues in the 
specific secondary sites and how these cues are transduced into biochemical signals and 
thereby controlling the proliferation of the cancer cells.    
Bone is one of the principal secondary locations for metastatic relapse and is 
composed of a porous matrix with embedded cells. The fluid-filled porous matrix 
comprises hydroxyapatite and collagen meshwork that provides ductile strength [189, 
190]. Bone is a complex mechanical microenvironment that undergoes constant 
remodeling due to the activity of bone-producing osteoblasts, bone-decaying osteoclasts 
and matrix-embedded osteocytes. The tumor cells colonize the marrow spaces of 
cancellous or spongy bones and depending on the microenvironmental cues either starts 




proliferating immediately or enters into an indefinite dormancy. Subsequently, when the 
environment becomes favorable for growth, a fraction of the dormant cells become re-
activated and proliferate to form macrometastases [191]. Therefore, the architecture or 
the topography of the bone undergoes dynamic remodeling in the porous matrix 
dimensions along with the progression of the metastatic disease. 
Invadopodia are actin rich mechanosensing structures that are produced by cancer 
cells to degrade and remodel the surrounding ECM by secretion of metalloproteinase. 
The formation of invadopodia by cancer cells is correlated with greater invasive potential 
in both in-vivo and in-vitro studies [192, 193]. ECM stiffness and cellular traction forces 
can regulate invadopodia numbers and activity, suggesting the role in sensing mechanical 
cues from the microenvironment [194]. For breast cancer cells, invadopodia-induced 
ECM degradation peaks around 30 kPa, which is in the same stiffness range as that of the 
desmoplastic stroma [195]. Multiple adhesive and contractile molecules form an adhesive 
ring at the base of the invadopodia, which are involved in probing and remodeling the 
environment using myosin-II based contractile forces. In fact, the formation of adhesion 
ring has been strongly correlated with invadopodial activity [196, 197]. Non-muscle 
myosin IIA co-localizes with the adhesion ring in 40% of the cells and are absent in these 
actin-rich structures, thereby suggesting the importance of global actomyosin based 
contractile forces in invadopodia-mediated mechanosening and matrix proteolysis [196].  
In this chapter, I will present how the topographic cues induced by the dynamic 
porous matrix of the bone affect cancer cell proliferation by fabricating well-defined 
micron-scale pits structures (known as micropits) of varying width and depth using micro 




fabrication tools. I will discuss our observations that micropits depth (but not width) 
reduced the proliferation of both non-cancer breast epithelial cells (MCF-10A) and 
malignant breast cancer cells (MDA-MB-231 and MCF-7). I will conclude by further 
supporting the concept of Mechanically-Induced DormancyDepth Sensing (MIDDS), where 
invadopodia could sense different depths of the porous matrix and cause reduction in 
the proliferation of both non-cancer breast epithelial cells and malignant breast cancer 
cells via differential regulation of Rho-Rac mediated actomyosin contractility.  
 
4.2. Methods 
4.2.1. Micro-fabrication of micropits topographic features 










4.2.2. Cell culture  
Non-cancer human breast epithelial cells (MCF-10A; American Type Culture 
Collection (ATCC)), human metastatic breast cancer cell line (MDA-MB-231; ATCC) 
and human non-metastatic breast cancer cell line (MCF-7; ATCC) were maintained and 
seeded on the PDMS features using the same protocol as mentioned in section 3.2.2. 
Membranes of 2 µm pore size (Millipore) were coated with 20 µg ml-1 collagen I and 
cells were seeded on top of them and cultured for 24 hours. 
 
4.2.3. Cell proliferation assay and fluorescent microscopy staining  
Proliferating cells were quantified using the same protocol as mentioned in 
section 3.2.3. Fold change of proliferation was calculated as the ratio of the proliferation 
percentage on micropits to that of the planar. To visualize the actin-rich protrusions, cells 
were fixed with 4% PFA and permeabilized with 0.01% Triton X‐100. F-actin was then 
stained using Green 488 phalloidin (Invitrogen) and imaged using Nikon Confocal A1R 
microscope. Protrusion length was quantified by selecting the region of interest along the 
z-axis using Imaris (Bitplane, Zurich, Switzerland). 300 cells were taken on an average 
for each experiment.   
 




4.2.4. Inhibitor treatment 
Inhibitor drugs were added using the same protocol as mentioned in section 3.2.4. 
The drugs used were: Blebbistatin (non-muscle Myosin II inhibitor; Sigma-Aldrich) (5, 
20 µM), Y-27632 (ROCK inhibitor; Sigma-Aldrich) (1, 10 µM), Rho activator II 
(activator of Rho GTPases; Cytoskeleton) (0.1, 0.25, 0.5 µg/ml), Rac1 inhibitor (prevents 
Rac1 activation; NSC23766; Sigma-Aldrich) (50, 100 µM), Arp 2/3 complex inhibitor 
(inhibitor of Arp2/3 mediated actin assemble; CK-666; Sigma-Aldrich) (10, 50, 100 
µM). 
 
4.2.5. Immunostaining and image analysis  
After culturing the cells on the micropits for required amount of time, cells were 
fixed with 4% PFA and permeabilized with 0.01% Triton X‐100 as mentioned 
previously. Subsequently, non-specific binding was blocked using 1% bovine serum 
albumin (BSA; Sigma-Aldrich) in 1X PBS for 1 hour. Cell were then incubated with 
primary antibody in 1% BSA for 1 hour at room temperature. Primary antibody was then 
washed three times with PBS and cells were incubated with fluorescent tagged-secondary 
antibody in 1% BSA for 1 hour at room temperature. Cells were then washed three times 
with PBS and nucleus of the cells were stained with DAPI. The primary antibodies used 
were: Anti-Cortactin (Cell Signaling Technology) at 1:500, Anti-Paxillin (Invitrogen) at 
1:400, Anti-phospho-ERK (1/2) (Cell Signaling Technology) at 1:500. Secondary 
antibodies from Alexa Fluor® (Invitrogen) were used.  




Cells were immunostained and imaged using Nikon Confocal A1R microscope. 
Protrusion length was visualized by selecting the region of interest along the z-axis using 
Imaris (Bitplane, Zurich, Switzerland). The p-ERK protein expression intensity of 
nucleus and cytoplasm was quantified using ImageJ software. Over 25 cells were 
analyzed under each condition.  
 
4.2.6. Western blot analysis 
Immunoblots were performed using the same protocol as mentioned in section 
3.2.6. Antibodies used were polyclonal phospho-ERK1/2 (CST), monoclonal ERK1/2 
(Santa Cruz) and monoclonal α-GAPDH (Santa Cruz).  
 
4.2.7. Statistics 













4.3. Results and Discussion 
4.3.1. Micropits depth reduces non-cancer breast epithelial cell proliferation 
 
Bone is one of the principal metastatic locations for breast cancer. The 
mechanical microenvironment of the bone undergoes dynamic changes along with the 
progression of metastasis. When the cancer cells arrive in their new secondary niche, 
they remain dormant for sometime and subsequently, they remodel the 
microenvironment by activating osteoclasts and thereby leading to the degradation of 
the porous matrix of the bone. Therefore, the pores widen (from few microns to 
hundreds of microns) and the patient becomes more prone towards severe bone pain 
and fracture. In order to better mimic the porous microenvironment of the bone in-
vitro using well-defined geometric structures, we used micro fabrication techniques to 
fabricate micropit of different widths and depths. To replicate the dynamic 
microenvironment, we fabricated the micropits across a range of steadily increasing 
pore width (W) of 2, 3 and 4 µm and depth (D) of 1.5, 3.8, 5.7, 7 and 9 µm (Table 
4.1). The successful replication of the micropits feature was verified using scanning 
electron microscope (SEM), as illustrated in Fig 4.1a. Micropits were coated with 
collagen matrix to facilitate cell adhesion and spreading and to better mimic the in-
vivo condition, since collagen is one of the principal constituents of the bone 
environment [189]. Cells were seeded on top of these collagen-coated structures and 
actin rich protrusions of varying lengths were observed along the depth of the 
micropits, as indicated by the schematic diagram (Fig 4.1b). Therefore, the cells might 




use these actin rich structures to sense the depth of the micropits and these structures 
serve as our region of interest (ROI). In order to have a clear view of the microscopic 
images of these structures, the subsequent images will be presented with the cell in an 
inverted position, that is, the basal side pointing upward.  
To understand the effect of micropits depth on the proliferation of non-cancer 
breast epithelial cells, MCF-10A cells were cultured on these collagen-coated 
structures of gradually increasing depth from 1.5 to 9 µm with a constant width of 2 
µm (Fig 4.1c). Cells were culture for 24 hours on these structures and subsequently 
fixed and stained with EdU that labels the nucleus of the proliferating cells. The 
proliferation of MCF-10A cells did not change for micropits with 1.5 µm depth 
compared to the planar case. This signifies that cells could not sense the difference 
between the planar and 1.5 µm depth of micropits and thereby leading to an alteration 
in proliferation. Interestingly, when the depth was further increased from 3.8 to 9 µm, 
MCF-10A proliferation decreased significantly. Therefore, cells could sense the depth 
of 3.8 µm or higher and cause a reduction in proliferation. Additionally, the depth 
sensing mechanism reaches a saturation level for depth of 3.8 µm and further increase 
in micropit depth does not lead to further decrease in proliferation. Next, we 
investigated the effect of the width of the micropits on MCF-10A proliferation, by 
seeding the cells on micropits of gradually increasing width from 2 to 4 µm keeping a 
constant depth of 9 µm (Fig 4.1d). The proliferation of MCF-10A decreased for all the 
widths of the micropits when the depth is kept constant at 9 µm. Therefore, the depth 
of the micropits plays a dominant role compared to its width in the reduction of MCF-




10A proliferation and this depth sensing mechanism approaches a saturation value for 
depth of 3.8 µm.  
Subsequently, we characterized how the length of the protrusions changes with 
respect to the alteration of depth and width of the micropits. We observed that as the 
micropits depth increases from 1.5 to 9 µm, the protrusion length also increases 
proportionally with a mean and highest protrusion length of 1.57 µm and 8.1 µm, 
respectively for 9 µm depth micropits (Fig 4.1e). It is interesting to note here that the 
mean protrusion length for 3.8 µm depth micropits is 0.90 µm, which signifies that at 
least 0.90 µm length of the actin rich protrusion is required for the cells to sense the 
topographic depth and thereby causing reduction in proliferation. However, when the 
width of the micropits were increased from 2 to 4 µm at a constant depth of 9 µm, the 
protrusion length did not change significantly and it maintained a constant mean value 
around 1.55 µm (Fig 4.1f).  Thus, a minimum mean protrusion length of 0.90 µm is 
required for depth sensing and reduction of MCF-10A proliferation and the width of 
the micropits do not have any effect on the protrusion length. Confocal microscopy 
representative images of the protrusion length of MCF-10A cells cultured on micropits 
of 1.5 µm (Fig 4.1g) and 9 µm (Fig 4.1h) depth, which depicts the distribution and 
heterogeneous length of the actin-rich protrusions. F-actin is stained with phalloidin 
(green) and the protrusion lengths were outlined in red using Imaris image analysis 
software.  
 






Figure 4.1. Micropits depth reduces non-cancer breast epithelial cell proliferation. 
(a) Scanning electron microscopic (SEM) representative images of micropits of different 
widths (2, 3, 4 µm) and depths (1.5, 3.8, 5.7, 7.0, 9.0 µm) respectively. Width scale 10 
µm and depth scale 5 µm. (b) Schematic representation of the micropits topographic 
pattern and morphology of the cells seeded on top of it. (c) Micropits depth greater than 
1.5 µm decreases MCF-10A proliferation after 24 hours of cell seeding. Data are means ± 
s.e.m. (n = 3). For each experiment, an average of 300 cells were considered. P values 
were obtained using student’s t-test. **p< 0.01 with respect to planar. (d) Proliferation 
reduction induced by micropits is not affected by altering the width of the micropits (2, 3, 




4 µm) at a constant depth (9 µm). (e) Cell protrusion length increases as the depth of the 
micropits is increased. (f) Protrusion length is not affected by the width of the micropits 
at a constant depth. N.S. denotes non-significant differences between the protrusion 
lengths for the different micropits width. Confocal microscopy representative images of 
the protrusion lengths of MCF-10A cells cultured on micropits of different depths [1.5 
µm (g) and 9 µm (h)]. (Phalloidin: Green, Region of interest indicated by Imaris 
software: Red; Scale 10 µm). 
 
4.3.2. Dynamics of micropit-induced dormancy of MCF-10A cells is independent of 
biochemical cues 
 
To further characterize the dynamics of micropits induced depth sensing 
mechanism, MCF-10A cells were cultured on micropits of 2 µm width and 9 µm depth 
for varying periods of time (Fig 4.2a).  The proliferation efficiency decreased for all 
the time points from 12 to 72 hours, which indicates that at least 12 hours is required 
for the transduction of depth sensing cues and thereby leading to proliferation 
reduction. Interestingly, the maximum reduction in proliferation occurred after 24 
hours of cell seeding (Fig 4.2b). The doubling time for MCF-10A cells is around 20 
hours [182]. However, the proliferation fold-change gradually increased from 36 to 72 
hours, which shows that the cells were steadily acquiring resistance against these depth 
sensing cues and approaching their normal proliferation rate as observed on planar 
surface. In other words, the depth sensing mechanism could induce a temporary 




dormancy or stoppage in the proliferation of MCF-10A cells and with the passage of 
time, the cells acquire resistance against these mechanical cues.  Then we 
characterized the dynamics of the protrusion length with passage of time (Fig 4.2c). 
We observed that the protrusion length does not change as the time increased from 12 
to 72 hours and maintained an average length around 1.5 µm. Thus, the cells were 
sustaining an equilibrium protrusion length that remains constant with the passage of 
time by maintaining a steady state between actin polymerization and depolymerization 
rates.  
Subsequently, we investigated whether depth sensing induced proliferation 
reduction of MCF-10A is dependent on the biochemical cues provided by the ECM 
such as collagen. To test this possibility, we seeded cells on poly-l-lysine (PLL) coated 
micropits, where cells adhere via electrostatic interactions instead of integrin mediate 
adhesion [198]. We observed that the proliferation of MCF-10A reduced similarly in 
both collagen and PLL coated micropits, which indicates that the depth sensing cues 
dominates over the biochemical cues provided by collagen matrix in decreasing MCF-
10A proliferation (Fig 4.2d). Another possible reason for the reduction of cell 
proliferation on the micropits could be the secretion of various soluble factors from the 
cells and concentrated as a gradient within the individual micro-pockets of the 
micropits structure, which might be responsible for the proliferation reduction.  To rule 
out this possibility, we seeded cells on collagen-coated membranes of 2 µm pores 
arranged in random orientation, where the bottom of the membrane is in contact with 
the culture media (Fig 4.2e). We observed that the proliferation still decreased on the 




membrane compared to planar surface and actin-rich protrusions are formed at the base 
of the membrane. This shows that depth-sensing cues reduces MCF-10A proliferation 











Figure 4.2. Micropits induces greatest reduction of MCF-10A proliferation after 24 
hours of cell seeding independent of biochemical cues. (a) Greatest reduction of MCF-
10A proliferation occurred after 24 hours of cell seeding (highlighted by red box). 
Growth curves of cells seeded on planar and micropits (W = 2 µm, D = 9 µm) are 
indicated by blue and red colored lines respectively. (b) Fold change calculation of 




proliferating MCF-10A cells as a function of time. (c) Protrusion length remains constant 
as time increases. N.S. denotes non-significant differences between the protrusion lengths 
for the different time points. (d) Micropits reduces MCF-10A proliferation across 
different extracellular matrix (ECM) coating such as collagen and Poly-L-Lysine (PLL). 
(e) MCF-10A proliferation is reduced by membranes of 2 µm pore size. Blue bar 
indicates planar and red indicates micropits (W = 2 µm, D = 9 µm). Bright field images of 
the membrane pore in random orientation. Confocal microscopy images of the protrusion 
lengths (indicated with white arrows) stained with phalloidin (green) for actin filaments 
(Scale 10 µm). Data are means ± s.e.m. (n= 3). For each experiment, an average of 300 
cells were considered. P values were obtained using student’s t-test. **p< 0.01 and *p< 
0.05 with respect to planar.  
 
4.3.3. Invadopodia decreases MCF-10A proliferation on micropits 
 
Subsequently, we wanted to characterize these structures and identify what are the 
molecules that co-localizes in these mechanosensitive actin-rich protrusions. To answer 
these questions, we performed cortactin and paxillin immunostaining of these protrusions 
at different depth. Interestingly, we observed that cortactin strongly co-localizes with 
these actin rich protrusions in both micropits of 9 µm (Fig 4.3a) and 1.5 µm depth (Fig 
4.4a), which provides the first hint that these protrusions are invadopodia. Co-
localization of cortactin and actin in these protrusive structures is considered as one of 
the key features of invadopodia, which the cell uses mainly to degrade the ECM [193, 




199]. Therefore, the depth sensing cues provided by the micropits that mimic the 
porous microenvironment of the bones are inducing the invasive potential of MCF-
10A cells, which results in the formation of invadopodia. To further confirm our 
findings, we observed that paxillin forms a ring-like structure at the base of the 
protrusions in 9 µm depth micropits and the actin cytoskeleton passes through the 
center of this ring (Fig 4.3b). But paxillin staining did not co-localize along the depth 
of the protrusive structures (Fig 4.4b). Another important characteristic of invadopodia 
is the formation of adhesive ring at the base of the protrusions comprising the adhesion 
related molecules such as paxillin, vinculin, focal adhesion kinases (FAK), Src and β1 
integrins [200]. The adhesive ring formation has been previously co-related with 
invadopodial activity and non-muscle myosin IIA localizes along these structures to 
provide contractile forces for sensing mechanical cues from the environment [196, 
197]. However, for 1.5 µm depth micropits, paxillin accumulated at the edges of the 
pores but did not form the adhesive ring (Fig 4.4c). The depth sensing mechanical cues 
provided by 1.5 µm depth might not be sufficient to lead to the formation of functional 
invadopodia and this result is consistent with the proliferation of MCF-10A, where at 
least 3.8 µm depth is required for the reduction of proliferation.  
 






Figure 4.3. Invadopodia decreases MCF-10A proliferation on micropits. (a) 
Protrusion length of MCF-10A cells cultured on 9 µm depth micropits was 
immunostained for cortactin (green) and actin (phalloidin, red) (Scale 10 µm). (b) 
Paxillin (immunostained in red) forms a ring at the base of the protrusions for micropits 
depth of 9 µm. Actin filaments are co-stained with phalloidin (green) (Scale 5 µm). (c) 
Arp2/3 inhibitor (CK-666; 50 µM) prevents the formation of invadopodia. White arrow 
indicates accumulation of actin filaments (phalloidin, green) at the base of the cell 
without forming the protrusions (Top view; Scale 10 µm) (Side view; region of interest 
(red) indicated by Imaris software, Scale 5 µm). Arp2/3 inhibitor (CK-666; 10, 50, 100 




µM) prevents depth induced proliferation reduction of MCF-10A cells. Data are means ± 
s.e.m. (n= 3). For each experiment, an average of 300 cells were considered. P values 
were obtained using student’s t-test. **p< 0.01 with respect to planar. Blue bar indicates 
planar and red indicates micropits (W = 2 µm, D = 9 µm). N.S. denotes non-significant 
difference compared to planar. 
 
To examine whether the depth sensing-induced invadopodia formation is 
responsible for the reduction of MCF-10A proliferation on the micropits, we inhibited 
invadopodia formation using Arp 2/3 complex (actin-related protein 2 and 3) inhibitor 
CK-666 and observed the proliferation of MCF-10A in the presence of different 
concentrations of the drug (10, 50, 100 µM). Arp 2/3 complex has previously been 
shown to play a critical role in invadopodia formation and reduced expression of 
Arp2/3 complex decreases invadopodia formation [193, 201]. In the presence of 50 µM 
CK-666, we observed complete retraction of invadopodia with actin accumulations at 
the base of the cells but these structures did not extend along the depth (Fig 4.3c). 
Interestingly, inhibition of Arp 2/3 complex, prevented depth sensing induced 
reduction of MCF-10A proliferation across the different concentrations of the drug 
used. In the presence of Arp 2/3 complex inhibitor that inhibits the invadopodia 
formation, cells cannot sense the difference between planar and micropits surface, 
which shows the involvement of invadopodia in sensing the depth of the micropits and 
reducing MCF-10A proliferation.       





Figure 4.4. Cortactin co-localizes with actin along the protrusions and paxillin 
accumulates around the micropits. (a) MCF-10A protrusions on 1.5 µm depth 
micropits were immunostained for cortactin (red) and actin (phalloidin, green) (Scale 5 
µm). (b) Cross-sectional view of paxillin (immunostained in red) accumulation near the 
base of the protrusions for micropits of 9 µm depth. F-actin is stained with phalloidin 
(green) (Scale 10 µm). (c) Paxillin (immunostained in red) accumulates near the base of 








4.3.4. Micropits depth reduces MCF-10A proliferation by activating actomyosin 
contractility and inactivating p-ERK signaling   	
Previous studies have shown the involvement of non-muscle myosin-II based 
contractility in regulating invadopodia activity and mechanosensing [196, 197]. We 
hypothesized that depth sensing induced temporary dormancy of MCF-10A via 
invadopodia formation might be due to the generation of Rho-Rac regulated actomyosin 
contractility within the cell. To test this hypothesis, we treated cells cultured on micropits 
with various concentrations of drugs that affect actomyosin contractility, such as 
blebbistatin (inhibitor of non-muscle myosin II based contractility) (5, 20 µM) and Rac1 
inhibitor (NSC23766; prevents Rac1 activation) (50, 100 µM) (Fig 4.5a). Interestingly, 
we observed that in the presence of Rac1 inhibitor, the proliferation of MCF-10A further 
decreased on micropits, as shown by the mean fold change of 0.56 and 0.45 for Rac1 
inhibitor concentration of 50 and 100 µM, respectively compared to 0.66 in case the of 
planar. Previous study have found that 50 and 100 µM of NSC23766 can reduce the 
activity of Rac1 GTPase by more than 50% [202]. Thus, Rac1 is already inhibited by 
depth sensing cues from micropits and when we further inhibited it using 
pharmacological drugs such as NSC23766, the proliferation reduces even further. In 
contrast, blebbistatin prevents the micropits induced proliferation reduction, which 
signifies the activation of Rho-ROCK-Myosin based contractility in sensing depth. In 
other words, in the presence of contractility inhibitory drugs, the cell cannot sense the 
difference between planar and micropits in terms of their proliferation response. 
Subsequently, we wanted to investigate whether there is any interplay or cross talk 




between the activation of Rho-ROCK-Myosin based contractility and Rac1 inhibition as 
shown in previous studies [203, 204]. To test this question, we used Rac1 inhibitor in the 
presence of blebbistatin and observed that in the presence of this double inhibition, the 
proliferation of MCF-10A again reduced on micropits to 0.73 and 0.62 mean fold change 
as the concentrations of the drug increased respectively. Therefore, when both the drugs 
were added simultaneously there is a rescue of phenotype compared to that observed in 
the case of only blebbistatin. These results imply that there is a cross talk between Rho-
ROCK-Myosin and Rac1 in depth sensing induced MCF-10A proliferation reduction. To 
further confirm our findings, we used other drugs that perturb actomyosin contractility, 
such as Rho activator II (activator of Rho GTPases) (0.1, 0.25, 0.5 µg/ml) and Y-27632 
(ROCK inhibitor) (1, 10 µM). Consistent with our earlier results, we observed that in 
the presence of Rho activator II, the proliferation was further reduced to mean fold 
change of 0.60, 0.58 and 0.57 along with the increasing concentration of the drug, 
respectively (Fig 4.5b). However, in the presence of Y-27632, there is no reduction of 
proliferation on micropits, similar to what was observed in the presence of blebbistatin 
(Fig 4.6a). Therefore, invadopodia mediated depth sensing cues could activate Rho-
ROCK-Myosin based contractility, which in turn inactivates Rac1 and there is a cross 
talk between them. Next, we looked into the effect of actomyosin contractility on the 
protrusion length of MCF-10A because myosin-II based contractile forces regulate the 
activity and mechanosensing ability of invadopodia, as shown in previous studies [196, 
205]. We observed that Rac1 inhibitor reduced the protrusion length, however, in 
presence of blebbistatin the protrusion length increased (Fig 4.6b). Thus, increasing 




contractile ‘pulling’ forces using Rac1 inhibitor causes a retraction of the protrusions, 
however, when the contractile forces were released using blebbistatin, the invadopodia 
length increased further. Additionally, when the two inhibitors were added 
simultaneously, the protrusion decreased compared to that observed in case of 
blebbistatin alone, which highlights the crucial interplay between Rho and Rac1 in 








Figure 4.5. Micropits decreases MCF-10A proliferation by activating actomyosin 
contractility and inactivating p-ERK signaling. Micropits reduces MCF-10A 
proliferation via inactivation of Rac and activation of Rho pathway. (a) Acto-Myosin 
contractility modulating drug treatment: Rac1 inhibitor (NSC23766; 50, 100 µM), 
Blebbistatin (5, 20 µM), and (b) Rho activator II (0.1, 0.25, 0.5 µg/ml). Data are means ± 
s.e.m. (n= 3). For each experiment, 300 cells were considered on an average. The number 
on top of the respective bar indicates mean fold change with respect to planar. (c) 
Immunofluorescence images of p-ERK (green) and nucleus (DAPI, blue) of MCF-10A 
cells grown on planar and micropits in absence and presence of different drugs 
respectively: Rho activator II (0.25 µg/ml), Arp2/3 inhibitor (CK-666; 50 µM) (Scale 25 
µm). (d) p-ERK fluorescence intensity quantification in nucleus/cytoplasm of MCF-10A 
cells. Over 25 cells were analyzed for each condition. P values were obtained using 
student’s t-test. **p< 0.01 with respect to planar. Blue bar indicates planar and red 
indicates micropits (W = 2 µm, D = 9 µm). The number on top of the respective bar 
indicates mean fold change with respect to planar. N.S. denotes non-significant difference 
compared to planar. 
 
Previous studies have shown that mechanical cues can control translocation of p-
ERK between the nucleus and cytoplasm to regulate gene expression while higher 
nuclear localization of p-ERK has been related to increased proliferation and vice versa 
[206-208]. We further explored whether depth sensing-induced reduction of MCF-10A 
proliferation is also mediated via differential translocation of p-ERK to the nucleus. To 




examine this possibility, we immunostained the cells seeded on micropits with p-ERK 
antibody. We observed that p-ERK has a diffused cytoplasmic distribution for cells 
cultured on micropits, however, it shuttles predominantly into the nucleus for cells on 
planar substrate (Fig 4.5c). Additionally, in presence of Rho activator II, we observed a 
similar trend of higher nuclear localization of p-ERK for cells grown on planar compared 
to micropits, which is quantified in Fig 4.5d. Interestingly, p-ERK fluorescence 
intensity ratio between nucleus and cytoplasm has a lower mean fold change of 0.51 
for Rho activator II compared to 0.66 for no inhibitor condition. This indicates that in 
presence of Rho activator II, p-ERK resides more in the cytoplasm for cells grown on 
micropits compared to no inhibitor. This predicts lower proliferation on micropits in 
presence of Rho activator II that is consistent with our previous proliferation data. In 
contrast, p-ERK localization did not show any significant difference between planar and 
micropits in presence of Arp 2/3 inhibitor. Thus, when invadopodia formation is inhibited 
using Arp 2/3 inhibitor, cells cannot realize the difference between planar and micropits, 
which is observed by no difference in p-ERK shuttling and proliferation efficiency. Cells 
cultured on micropits expressed less amount of p-ERK compared to the ones cultured on 
planar substrates (Fig 4.6c). However, in the presence of blebbistatin, there is no 
difference in the expression of p-ERK between the cells grown on planar and micropits, 
which indicates that micropits reduces MCF-10A proliferation by activating cellular 
contractility and by decreasing p-ERK expression as well as preventing it from 
translocating into the nucleus.  
 





Figure 4.6. MCF-10A proliferation and invadopodia length in regulated by 
actomyosin contractility. (a) 9 µm depth micropits decreases MCF-10A proliferation via 
activation of actomyosin contractility. Acto-Myosin contractility inhibitor treatment: Y-
27632 (1, 10 µM). Data are means ± s.e.m. (n= 3). For each experiment, 300 cells were 
considered on an average. P values were obtained using student’s t-test. **p< 0.01 with 
respect to planar. Blue bar indicates planar and red indicates micropits (W = 2 µm, D = 9 
µm). N.S. denotes non-significant difference compared to planar. (b) Actomyosin 
contractility decreases protrusion length. Acto-Myosin contractility modulating drug 
treatment: Rac1 inhibitor (NSC23766; 50 µM) and Blebbistatin (20 µM). (c) Lysates 




from MCF-10A cells grown on planar (PL) or micropits (MP) were separated by SDS-
PAGE gel and immunoblotted (IB) with antibodies for phospho-ERK1/2 (pERK1/2), 
total ERK1/2 (pan ERK1/2) and α-GAPDH as loading control.  
 
4.3.5. Depth sensing reduces malignant breast cancer cell proliferation by 
inactivating actomyosin contractility and p-ERK signaling  
 
We subsequently explored how the malignant breast cancer cells (MCF-7, MDA-
MB-231) interact with depth sensing cues arising from micropits to control their 
proliferation response.  We seeded non-metastatic breast cancer cells (MCF-7) on the 
micropits with different depth and widths and observed that 9 µm depth micropits of 
different width (2, 3 and 4 µm) reduces MCF-7 proliferation (Fig 4.7a). However, 1.5 
µm depth micropits with varying width did not cause any reduction in proliferation, 
which signifies the dominant role played by the depth of the micropits instead of the 
width in reducing MCF-7 proliferation that is consistent with MCF-10A observations. 
We also observed that MCF-7 cells extended actin rich protrusions to sense the micropits 
depth and the length of the protrusions are higher for 9 µm depth (mean protrusion 1.72 
µm) compared to 1.5 µm depth (mean protrusion 0.79 µm) (Fig 4.7b). Subsequently, 
we characterized the depth sensing response of metastatic breast cancer cells (MDA-
MB-231), and in consistent with our previous findings for MCF-10A and MCF-7; we 
observed that MDA-MB-231 proliferation is reduced by 9 µm depth of the micropits 
instead of the varying width (Fig 4.8a). We noticed actin-rich protrusions of varying 




length and identified these protrusions as invadopodia by the co-localization of 
cortactin and actin for 9 µm depth micropits (Fig 4.8b). Interestingly, in contrast to 
MCF-10A, the actin-rich protrusions in MDA-MB-231 were not completely inhibited 
(mean protrusion 1.06 µm) in the presence of Arp 2/3 complex inhibitor (CK-666; 50 
µM) compared to no inhibitor condition (mean protrusion 2.03 µm) (Fig 4.8c). Previous 
study has shown that three members from diaphanous-related formins (DRF) family 
(DRF1 - DRF3) are involved in the formation and activation of invadopodia in MDA-
MB-231 cells [209]. Therefore, in the presence of Arp 2/3 complex inhibitor, only the 
Arp 2/3 mediated branched actin network is disrupted but the linear filaments formed by 
formins are not affected, thereby causing a partial retraction of the protrusions. However, 
in presence of different concentrations of Arp 2/3 complex inhibitor (CK-666; 10, 50, 
100 µM), the proliferation of MDA-MB-231 did not reduce on micropits compared to the 
planar, which indicates that invadopodia formation is essential for depth sensing and 
reducing MDA-MB-231 proliferation (Fig 4.8d).     
 
 





Figure 4.7. Non-metastatic breast cancer cell (MCF-7) proliferation decreases on 9 
µm depth micropits but not on 1.5 µm depth. (a) Micropits depth of 9 µm (but not of 
1.5 µm) reduces MCF-7 proliferation across different width (2, 3, 4 µm). (b) Protrusion 
length is greater on 9 µm depth micropits at a constant width of 2 µm. Data are means ± 
s.e.m. (n= 3). For each experiment, 200 cells were considered on an average. P values 
were obtained using student’s t-test. **p< 0.01 with respect to planar. N.S. denotes non-
significant difference compared to planar. 
 






Figure 4.8. Metastatic breast cancer cell (MDA-MB-231) proliferation decreases on 
9 µm depth micropits but not on 1.5 µm depth via invadopodia formation. (a) 
Micropits depth of 9 µm (but not of 1.5 µm) reduces MDA-MB-231 cell proliferation 
across different width (2, 4 µm). (b) Cortactin (immunostained in red) co-localizes with 
actin (phalloidin in green) in the protrusions of 9 µm depth micropits (Scale 10 µm). (c) 
Arp 2/3 inhibitor (CK-666; 50 µM) partially inhibits the protrusion length. (d) Arp2/3 
inhibitor (CK-666; 10, 50, 100 µM) prevents the depth induced proliferation reduction of 
MDA-MB-231 cells. Data are means ± s.e.m. (n= 3). For each experiment, 300 cells were 
considered on an average. P values were obtained using student’s t-test. **p< 0.01 with 




respect to planar. Blue bar indicates planar and red indicates micropits (W = 2 µm, D = 9 
µm). N.S. denotes non-significant difference compared to planar.  
 
We further characterized the invadopodia of MDA-MB-231 cells by quantifying 
its protrusion lengths. Cells extended longer invadopodia for 9 µm depth (mean 
protrusion 2.03 µm) compared to 1.5 µm depth (mean protrusion 0.87 µm) (Fig 4.9a). 
Additionally, MDA-MB-231 proliferation was reduced by 2 µm pore membrane 
compared to planar case and formation of actin-based protrusions were observed at the 
base of the membrane. This shows that MDA-MB-231 proliferation was reduced by 
invadopodia-mediated depth sensing cues independent of biochemical cues and 
orientation of the pores (Fig 4.9b). Next, we examined the localization of cortactin and 
paxillin in the invadopodia structures of different depths using immunostaining. We 
observed that for 1.5 µm depth micropits, cortactin localizes with actin in the shorter 
invadopodia (Fig 4.9c) and paxillin staining was observed at the edges of the pores 
(Fig 4.9d), similar to that of MCF-10A. However, for 9 µm depth, paxillin formed a 
ring like structure around the pores with the actin cytoskeleton passing through the 
middle, which indicates the formation of functional invadopodia for micropits of 
greater depth (Fig 4.9e).  Invadopodia formation has been previously correlated with 
the invasive potential of the cells [192, 193]. So, we quantified the length of the 
invadopodia for the three different breast cell lines according to their increasing 
invasive characteristics, such as MCF-10A, MCF-7 and MDA-MB-231. Interestingly, 
we observed that for 9 µm depth micropits, the protrusion length increases 




proportionally to the invasive potential of the cells (Fig 4.10). This result implies that 
as the cell becomes more metastatic, they extended longer actin protrusions to degrade 
the matrix using metalloproteinase and the length of the invadopodia could be good 




Figure 4.9. Invadopodia decreases MDA-MB-231 proliferation independent of 
biochemical cues. (a) Protrusion length is greater on 9 µm depth micropits at a constant 
width of 2 µm. (b) MDA-MB-231 proliferation is reduced by membranes of 2 µm pore 
size. Confocal microscopy images of the protrusion lengths (indicated with white arrows) 




stained with phalloidin (green) for actin filaments (Scale 10 µm). Data are means ± s.e.m. 
(n= 3). For each experiment, 200 cells were considered on an average. P values were 
obtained using student’s t-test. **p< 0.01 with respect to planar. (c) Cortactin 
(immunostained in red) co-localizes with actin (phalloidin in green) in the protrusions of 
1.5 µm depth micropits (Scale 5 µm). (d) Paxillin (immunostained in red) accumulates 
near the base of the protrusions for micropits depth of 1.5 µm (Scale 5 µm). (e) Paxillin 
(immunostained in red) forms a ring at the base of the protrusions for micropits depth of 
9 µm. Actin filaments are co-stained with phalloidin (green) (Scale 5 µm). 
 
		
Figure 4.10. Protrusion length increases proportionally to metastatic potential. Cells 
were cultured on micropits of W = 2 µm, D = 9 µm. P values were obtained using 
student’s t-test. **p< 0.01. 





Next, we investigated how the actomyosin contractility is regulated by 
invadopodia-mediated depth sensing for MDA-MB-231 cells. We treated the cells 
cultured on micropits with varying concentrations of drugs that regulate cellular 
contractility, such as blebbistatin (5, 20 µM) and Rac1 inhibitor (NSC23766) (50, 100 
µM) (Fig 4.11a). In the presence of Rac1 inhibitor, there is no difference in proliferation 
between the planar and micropits, which indicates that Rac1 is activated within the cell 
and when we are preventing this activation using drugs, the cell cannot respond to the 
depth sensing cues. Interestingly, MDA-MB-231 proliferation was strongly reduced in 
presence of 50 µM NSC23766 compared to that of MCF-10A (Fig 4.5a). Previous 
studies have also observed that mesenchymal cancer cells [210] show greater reduction in 
proliferation in presence of Rac1 inhibitor compared to that of epithelial cancer types 
[211]. However, further studies with different cell types are required to support the 
conclusion that these effects are signatures of epithelial and mesenchymal phenotypes. 
Surprisingly, blebbistatin treatment further reduces the proliferation of MDA-MB-231 on 
micropits with mean fold change of 0.68 and 0.59 for 5 and 20 µM concentration of 
blebbistatin, respectively as compared to 0.76 for no inhibitor control. Thus, in 
contradiction to MCF-10A, depth-sensing cues are inhibiting acto-myosin contractility of 
MDA-MB-231 cells and in presence of pharmaceutical drugs that inhibit contractility; the 
proliferation rate decreases further on micropits. Then we examined whether there is any 
interplay between Rac1 activation and inhibition of Rho-ROCK-Myosin based 
contractility as was previously observed with MCF-10A. To test this possibility, we 




treated the cells with both blebbistatin and Rac1 inhibitor and observed that there was a 
rescue in phenotype in the presence of the double inhibitors compared to that of 
blebbistatin alone. In other words, with both inhibitors, the difference in proliferation 
between planar and micropits gradually diminished as the concentration of the drugs 
increased. This indicates that there is a cross talk between actomyosin contractility and 
Rac1 in reducing MDA-MB-231 proliferation in response to depth sensing cues. To 
further confirm our observations, we used other drugs that regulate actomyosin 
contractility, such as Y-27632  (1, 10 µM) and Rho activator II (0.1, 0.25, 0.5 µg/ml). 
Consistent with our previous results, we observed that inhibiting contractility using Y-
27632 further reduced MDA-MB-231 proliferation on micropits to mean fold change of 
0.71 and 0.65 for 1 and 10 µM concentration of the drug compared to 0.77 for no 
inhibitor condition (Fig 4.12a). However, activating contractility using Rho activator II 
prevented micropits induced proliferation reduction (Fig 4.12b). Therefore, for MDA-
MB-231 cells, invadopodia mediated depth sensing cues could inhibit actomyosin 
contractility, which in turn activates Rac1 and there is a cross talk between them. 
Subsequently, we investigated the dynamics of blebbistatin mediated greater reduction of 
MDA-MB-231 proliferation on micropits for different periods of time. Similar to MCF-
10A, we observed that the greatest reduction of proliferation occurred after 24 hours of 
cell seeding for both no inhibitor and blebbistatin treatment condition (Fig 4.11b). The 
doubling time for MDA-MB-231 cells is around 28 hours [212]. Interestingly, 24 
hours of blebbistatin treatment reduced MDA-MB-231 proliferation to 0.55 mean fold-
change compared to 0.7-fold change for no inhibitor condition (Fig 4.11c). This 




provides a potential opportunity for therapeutic intervention, where contractility-
inhibiting drugs and depth sensing mechanism could selectively induce 0.55 fold 
reduction of malignant cancer cell proliferation without affecting the proliferation of 
non-cancer epithelial cells. However, with the passage of time, MDA-MB-231 cells 
acquire resistance against these depth-sensing cues and gradually approach their 
normal proliferation efficiency as that on planar surface. We then examined the effect 
of contractility on the invadopodia length of MDA-MB-231 and observed that, similar to 
MCF-10A, in the presence of Rac1 inhibitor, the protrusions retracted due to increased 
contractile forces and blebbistatin treatment leads to further extension of the protrusions 
due to the release of contractile forces (Fig 4.12c). However, in presence of double 
inhibition, there is a reduction in invadopodia length compared to blebbistatin alone, 












Figure 4.11. Depth sensing decreases malignant breast cancer cell proliferation by 
inactivating actomyosin contractility and p-ERK signaling. Micropits decreases 
MDA-MB-231 proliferation by inactivating actomyosin contractility and p-ERK 
signaling. (a) Acto-Myosin contractility modulating drug treatment: Rac1 inhibitor 
(NSC23766; 50, 100 µM) and Blebbistatin (5, 20 µM). Data are means ± s.e.m. (n= 3). 
For each experiment, an average of 300 cells were considered. P values were obtained 
using student’s t-test. **p< 0.01, *p< 0.05  with respect to planar. Blue bar indicates 
planar and red indicates micropits (W = 2 µm, D = 9 µm). The number on top of the 
respective bar indicates mean fold change with respect to planar. N.S. denotes non-




significant difference compared to planar. (b) Greatest reduction of MDA-MB-231 
proliferation occurred after 24 hours of cell seeding (highlighted by red box) in absence 
and presence of Blebbistatin (20 µM). Growth curves of cells seeded on planar and 
micropits (W = 2 µm, D = 9 µm) are indicated by blue and red colored lines respectively. 
(c) Fold change calculation of proliferating MDA-MB-231 cells as a function of time in 
absence and presence of Blebbistatin (20 µM). (d) Immunofluorescence images of p-
ERK (green) and nucleus (DAPI, blue) of MDA-MB-231 cells grown on planar and 
micropits in absence and presence of different drugs respectively: Rho activator II (0.25 
µg/ml), Arp2/3 inhibitor (CK-666; 50 µM) (Scale 10 µm). 
 
   We then investigated whether the differential depth induced reduction of MDA-
MB-231 proliferation is coupled with the translocation of p-ERK into the nucleus. To 
explore this further we immunostained MDA-MB-231 cells cultured on micropits with p-
ERK antibody. We observed that p-ERK has a predominant cytoplasmic localization for 
cells cultured on micropits, which is in contrast to the nuclear localization of p-ERK for 
cells cultured on planar (Fig 4.11d). However, in presence of Rho activator II, there is no 
difference in the p-ERK fluorescence intensity ratio between nucleus and cytoplasm for 
planar and micropits (Fig 4.12d). This indicates that when the contractility of the cell is 
increased using Rho activator II, the cell cannot sense the difference between planar and 
micropits and this results in no difference in the p-ERK localization and proliferation 
efficiency. Additionally, when the invadopodia mediated depth sensing mechanism is 
inhibited using Arp2/3 complex inhibitor, there is no significant difference of p-ERK 




intensity between planar and micropits. However, there is no difference in p-ERK 
expression between the cells cultured on planar and micropits for no inhibitor and 
blebbistatin treatment that could possibly be due to the rapid shutting of p-ERK between 
the cytosol and nucleus on micropits surface (Fig 4.12e). Therefore, MDA-MB-231 
senses matrix depth using invadopodia, which subsequently inhibits actomyosin 
contractility and reduces proliferation predominantly by preventing p-ERK translocation 
into the nucleus via the activity of some signaling pathways that holds back p-ERK in the 
cytosol, rather than by decreasing the overall p-ERK protein expression.     
 
				




Figure 4.12. Actomyosin contractility and p-ERK signaling regulate MDA-MB-231 
proliferation and invadopodia length. 9 µm depth micropits decreases MDA-MB-231 
proliferation via inactivation of actomyosin contractility. Acto-Myosin contractility 
modulating drug treatment: (a) Y-27632 (1, 10 µM), (b) Rho activator II (0.1, 0.25, 0.5 
µg/ml). Data are means ± s.e.m. (n= 3). For each experiment, 300 cells were considered 
on an average. The number on top of the respective bar indicates mean fold change with 
respect to planar. (c) Actomyosin contractility decreases protrusion length in MDA-MB-
231 cells. Acto-Myosin contractility modulating drug treatment: Rac1 inhibitor 
(NSC23766; 50 µM) and Blebbistatin (20 µM). (d) p-ERK fluorescence intensity 
quantification in nucleus/cytoplasm of MDA-MB-231 cells in absence and presence of 
different drugs respectively: Rho activator II (0.25 µg/ml), Arp2/3 inhibitor (CK-666; 50 
µM). Over 25 cells were analyzed for each condition. P values were obtained using 
student’s t-test. **p< 0.01 with respect to planar. Blue bar indicates planar and red 
indicates micropits (W = 2 µm, D = 9 µm). N.S. denotes non-significant difference 
compared to planar. (e) Lysates from MDA-MB-231 cells grown on planar (PL) or 
micropits (MP) were separated by SDS-PAGE gel and immunoblotted (IB) with 
antibodies for phospho-ERK1/2 (pERK1/2), total ERK1/2 (pan ERK1/2) and α-GAPDH 
as loading control. 
 
4.4. Summary 




In summary, we observed the existence of Mechanically-Induced Dormancy 
through Depth Sensing (MIDDS), where cells could sense the different depths of the ECM 
using actin-enriched protrusions such as invadopodia and transduce a mechanical cue to 
regulate the contractile machinery, thereby causing proliferation reduction (Fig 4.13). 
The mechanical microenvironment of the bone, which is one of the principal metastatic 
sites, undergoes continuous remodeling due to the regulated activity of bone forming 
osteoblasts and bone degrading osteoclasts. When the cancer cells reach the bone niche 
through the circulatory system, they either undergo long-term dormancy (for breast 
cancer [7, 213]) by adapting to the new microenvironment or they start proliferating 
immediately (for lung cancer [8]), depending on the particular cancer type. While 
adapting to their “new home”, the cancer cells could reprogram the pre-osteoblasts using 
soluble factors to make the environment favorable for its own growth [191]. As a result 
of which, the activity of the osteoclasts increases that results in bone degradation, 
increased porosity of the matrix and subsequently leading to severe bone pain and 
fracture in the advance stages of the metastatic disease. However, it was not known 
previously what is the effect of this constantly evolving pore dimensions on the 
proliferation efficiency of cancer cells.   
 





Figure 4.13. Schematic representation of differential depth sensing regulated by 
Mechanically-Induced DormancyDepth Sensing (MIDDS) of cancer cells. Cells could sense 
the differential depth of the matrix using actin-enriched protrusions such as invadopodia. 
For MCF-10A cells, depth-sensing cues could activate actomyosin contractility and 
prevent translocation of p-ERK into the nucleus, thereby causing proliferation reduction. 
In contrast, MDA-MB-231 cell proliferation is reduced via inactivation of myosin-II 
based contractility and p-ERK signaling. (+) sign, green color and point-ended arrows 
denotes activation of the signaling process and (–) sign, red color and blunt-ended arrows 
indicates inactivation of the phenomenon.  
 




In the previous chapter, we introduced the concept of Mechanically-Induced 
Dormancy (MID), whereby anisotropic cues provided by the aligned collagen fibers of 
the primary breast tumor environment could reduce the proliferation of non-cancer breast 
epithelial cells via activation of actomyosin contractility, but the malignant breast 
cancer cells somehow bypasses these growth inhibitory cues and continue their 
uncontrolled proliferation. In this chapter, we examined the effect of the dynamic 
mechanical niche of the bone on cancer cell proliferation using micropits of specific 
dimensions to mimic the physiological porous environment. We observed that the depth 
of the micropits (but not the width and the orientation) could reduce the proliferation of 
both normal and malignant breast cancer cells using mechanosensing structures such as 
invadopodia. Therefore, these findings show the role of invadopodia as a depth sensor 
and its ability to regulate proliferation ability of cells, apart from its well-known function 
of matrix degradation and remodeling. Non-cancer breast epithelial cells respond to these 
depth-sensing cues via activation of Rho-Rac regulated actomyosin contractility that 
subsequently inactivates the translocation of p-ERK into the nucleus. In contrast, 
metastatic breast cancer cells inactivate Rho-Rac controlled actomyosin contractility and 
p-ERK shuttling into the nucleus to cause reduced proliferation on micropits. Previous 
studies have shown a positive correlation between the expression of RhoA and ROCK1 
and metastatic potential, which signifies the importance of the contractile forces during 
metastasis of breast cancer [214, 215]. Interestingly, the expressions of contractile 
proteins such as RhoA, ROCK1 and phospho-myosin light chain are lowered in MCF-
10A compared to MDA-MB-231. Therefore, depending on its metastatic potential, cells 




uses different signaling mechanism to sense identical micro environmental cues to cause 
proliferation changes. This presents an opportunity for potential therapeutic intervention, 
where contractility inhibiting drugs could selectively reduce the proliferation ability of 
the cancer cells and induce dormancy while the healthy cells proliferation remain 
unaffected. Chemotherapeutic drugs targeting myosin II based contractility and matrix 
adhesion machinery such as integrin targeting agent Cilengitide [216] and focal adhesion 
kinase inhibitor TAE226 [217] have already started to emerge. Thus, our study provides a 
mechanistic perspective on the selective action of contractility targeting 
chemotherapeutic drugs on cancer cells in their metastatic niche, without affecting the 
healthy cells. However, cells tend to develop resistance against these proliferation 
inhibitory mechanical cues with the passage of time. Identifying the resistance acquiring 
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Chapter 5 
Conclusions and future perspectives  
5.1. Conclusions 
Blood-borne metastasis from a primary epithelial tumor is one of the main causes 
of cancer related deaths. Cancer cells that are released from the primary tumor through 
the circulation sow a seed for secondary metastatic tumor. Understanding how cancer 
cells establish distant lesions in the lung, brain, liver, or bone is challenging. Various 
biochemical components secreted by the stromal cells of the metastatic niche contribute 
to the specificity of the secondary location. However, it is not well understood whether 
the physical microenvironmental factors of the metastatic niche such as ECM stiffness, 
dimensionality, and topography have a role in influencing the proliferation and 
colonization efficiency of the tumor cells.  
This thesis is focused on understanding the role of the topographic cues on 
influencing the proliferation of cancer cells. The topographic features of the breast tumor 
microenvironment undergoes dynamic remodeling due to the activation of the stromal 
cells and this particular arrangement correlates with the progression of the metastatic 
disease. Here, we mimicked such topographic dimensions in-vitro using microfabrication 
tools and observed its effect on the proliferation of the cells. We subsequently studied 
how these mechanical cues are transduced into biochemical responses and suggest 
potential drug targets to inhibit cancer cell proliferation by combining the effect of the 
topographic cues and inhibitors targeting the mechanotransduction signaling pathways.  
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In chapter 3, we elucidated the effect of the anisotropic topographic cues induced 
by the primary breast tumor microenvironment on the proliferation of breast cancer cells. 
The tumor niche undergoes dynamic remodeling into a highly organized anisotropic 
arrangement due to the activation of the stromal cells. This particular arrangement helps 
in the invasion of the cancer cells away from the primary tumor with greater persistence 
and velocity.  However, it was previously unknown what is the role of this anisotropic 
cues in influencing the proliferation of the cancer cells. Here, we replicated such 
anisotropic cues in-vitro using microgratings topographic features of specific dimensions. 
We observed that microgratings reduced the proliferation of non-cancer breast epithelial 
cells and induced a temporary dormancy. However, the proliferation of malignant breast 
cancer cell lines remains unaffected in presence of these growth inhibitory topographic 
cues. Subsequently, we discovered that Rho-ROCK-Myosin based contractile forces in 
cells are responsible for sensing these topographic cues and decrease in proliferation. As 
such, we observe the existence of a Mechanically Induced Dormancy (MID) phenomenon 
where microstructures can inhibit normal cell proliferation but the cancer cells can 
successfully overcome this inhibition and continue uncontrolled growth.    
In chapter 4, we examined how the dynamic microenvironment of the bone affect 
cancer cell proliferation using micropits topographic features that mimic the porous 
matrix of the bone. Bone is one of the principal secondary niches for breast cancer 
metastasis and when the cancer cells reaches their metastatic location, they increases the 
activity of the osteoclasts to cause bone degradation and increased porosity of the matrix. 
However, it was previously unknown how the dynamic pore dimensions of the bone 
affect cancer cell proliferation ability. We observed that cells could sense the depth of the 
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pores (but not the width) and reduce the proliferation of both healthy and cancer cells 
using mechanosensing structures such as invadopodia. Cells protrude invadopodia to 
sense the depth of the matrix via contractile forces, which subsequently affects p-ERK 
signaling and proliferation efficiency. Therefore, these findings show the role of 
invadopodia as a depth sensor and its ability to regulate proliferation ability of cells, apart 
from its well-known function of matrix degradation and remodeling. Cancer and healthy 
cells respond to the same depth sensing cues using contrasting mechanisms. For healthy 
cells, depth sensing activates actomyosin contractility, however for malignant cells, 
actomyosin contractility is inhibited in response to the depth of the matrix. Thus, in 
presence of 20 µM blebbistatin, proliferation of MDA-MB-231 reduces by 0.5 fold on 
micropits but MCF-10A proliferation remains unaffected. This unfolds potential targets 
for chemotherapeutic intervention, whereby the combination of growth inhibitory 
mechanical cues and pharmaceutical drugs could induce 0.5 fold reduction of tumor cell 
proliferation without affecting the normal cells. Our results further supports the existence 
of Mechanically-Induced DormancyDepth Sensing (MIDDS) where invadopodia mediated 
depth sensing could inhibit the proliferation of non-cancer and malignant breast cancer 
cells through differential regulation of actomyosin contractility [218]. 
Taken together, this study highlights the importance of the mechanical 
microenvironment of the metastatic niche in dictating proliferation ability of cancer cells. 
In this thesis we introduce the concept of MID, where topographic cues from the primary 
and secondary breast microenvironment could induce a temporary halt in the proliferation 
of the cells via differential regulation of actomyosin contractility. Anisotropic cues and 
depth sensing cues could activate Rho-ROCK-Myosin based contractile forces and 
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reduce the proliferation of MCF-10A cells. Therefore, healthy cells use similar 
contractile mechanism to sense different topographic cues in the primary and secondary 
breast tumor microenvironment. Contrastingly, in MDA-MB-231, actomyosin 
contractility and p-ERK signaling is inhibited in response to depth sensing cues to reduce 
the proliferation of metastatic cells. Therefore, depending on the metastatic potential, 
cells adapt to an identical microenvironmental cue (depth of the matrix) using different 
signaling mechanisms. As such, this can potentially leads to strategies to selectively 
target the cancer cells in their secondary niche. 
 
5.2. Future perspectives 
               With this thesis, we have established some knowledge about the topography 
sensing mechanisms of healthy and malignant breast cancer cells. We have shown that 
the contractile machinery of the cells plays a significant role in the mechanotransduction 
phenomenon. This thesis provides a crucial platform to control the topographic response 
of the cancer cells and develop mechano-inspired strategies to target the metastatic cells 
in their niche without affecting the healthy cells. Therefore, we have opened up the 
avenues for interesting future directions: 
1. In this thesis, we have taken a candidate-based approach and elucidated the 
role of actomyosin contractility during topography sensing. Apart from this 
interesting mechanism, there might be several other signaling pathways that 
are getting affected in response to these mechanical cues. To explore more on 
those other signaling modules, a RNA-sequencing could be performed with 
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the cells seeded on the different topographic features to have an understanding 
of the entire signaling machinery that is getting affected in presence of the 
topographic cues. 
2. This thesis is based on the experimental results performed with the model 
breast cancer cell lines. However, it would be interesting to understand the 
physiological and clinical relevance of the concept of MID. To test this idea, 
clinical samples such as cultured circulating tumor cells (CTCs) and cancer 
organoids could be used to grow on these topographic features. 
3. Interestingly, in this study we observed differential response of healthy and 
cancer cells in presence of the same topographic cues. It will be intriguing to 
understand the molecular mechanisms responsible for the differential response 
and to induce sustained dormancy of the cancer cells. This could lead to better 
therapeutic design to selectively target the cancer cells without affecting the 
non-cancer cells. Based on previous literatures, tyrosine phosphorylation 
pathways involving Src and FAK and integrin independent pathways 
(Discoidin Domain Receptors (DDRs), a sub family of tyrosine kinase 
receptors) could be of special interest [181].  
4. In chapter 4, the micropits topography provides a well defined, easy to 
fabricate mechano-inspired system to induce invadopodia formation in-vitro 
using mechanical cues. This provides the opportunity to characterize the 
biophysical and molecular signaling events associated with invadopodia 
dynamics and activity. 
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5. Additionally, it could be used as a drug-screening platform to examine the 
efficiency of chemotherapeutic drugs targeting the invasive machinery of the 
cancer cells.  
6. Moreover, depth sensing cues provided by the micropits could lead to better 
design of tissue engineering scaffolds and implants to dictate specific cellular 
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